fibrinogen has been researched along with Chronic Disease in 330 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 154 (46.67) | 18.7374 |
1990's | 46 (13.94) | 18.2507 |
2000's | 79 (23.94) | 29.6817 |
2010's | 43 (13.03) | 24.3611 |
2020's | 8 (2.42) | 2.80 |
Authors | Studies |
---|---|
Carletti, C; Diamanti, D; Gori, E; Lubas, G; Marchetti, V; Pasquini, A; Pierini, A | 1 |
Bai, T; Chen, C; Peng, T; Wang, L; Wu, X; Zhang, N; Zhang, T | 1 |
Augello, AF; Carloni, S; De Matteis, S; Fattori, PP; Ghetti, M; Giordano, G; Lucchesi, A; Martinelli, G; Musuraca, G; Napolitano, R; Poggiaspalla, M | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Bu, L; Cho, B; Elisia, I; Hay, M; Jia, W; Krystal, G; Lam, S; Lam, V; Li, MY; Norton, N; Yeung, M | 1 |
Bjørnvad, CR; Krogh, AKH; Lyngby, JG; Nielsen, LN | 1 |
Grodzicki, T; Guzik, T; Mikołajczyk, T; Rewiuk, K; Seweryn, M; Sulicka-Grodzicka, J; Surdacki, A | 1 |
Abed, SY; El-Mesery, A; El-Mesery, M; El-Mowafy, M; Elgaml, A; Youssef, LF | 1 |
Akinkuolie, AO; Buring, JE; Chandler, PD; Lawler, PR; Lee, IM; Manson, JE; Mora, S; Ridker, PM; Tobias, DK; Wang, L | 1 |
Kolkhir, P; Olisova, O; Pogorelov, D | 1 |
Bazinet, RP; Festa, A; Haffner, SM; Hanley, AJ; Liese, AD; Lorenzo, C; Rewers, MJ; Santaren, ID; Wagenknecht, LE; Watkins, SM | 1 |
Bleier, BS; Dillon, ST; Libermann, TA; Mueller, SK; Nocera, AL; Wu, D | 1 |
Jaffee, SR; Milaniak, I | 1 |
Albareda, MC; Alvarez, MG; Bertocchi, G; Cambiazzo, SS; Castro Eiro, MD; Cesar, G; Laucella, SA; Lococo, B; Natale, MA; Nuñez, M; Pengue, C; Perroni, N; Viotti, R | 1 |
Corley, J; Deary, IJ; Hébert, JR; Shivappa, N; Starr, JM | 1 |
Cui, N; Gan, HL; Li, JF; Liang, Y; Lin, Y; Liu, J; Wang, C; Wang, J; Yang, SQ; Yang, YH; Zhai, ZG; Zhang, WJ; Zhao, L | 1 |
Chen, Y; Cui, J; Fu, BB; Jiang, DW; Li, GF; Wan, JX | 1 |
Kitamura, N; Matsuhisa, F; Satoh, E | 1 |
Agudo-Conde, C; de-la-Cal-Dela-Fuente, A; García-Ortiz, L; Gomez-Marcos, MA; Martin-Borras, C; Martinez-Vizcaino, V; Patino-Alonso, MC; Recio-Rodríguez, JI; Sanchez-Perez, A; Sauras-Llera, I | 1 |
Arturi, F; Fiorentino, TV; Perticone, F; Perticone, M; Sciacqua, A; Sesti, G; Succurro, E | 1 |
Chen, H; Cui, Q; Qin, L; Shen, H; Wang, Z; Wu, T; Yu, Z | 1 |
Baumann, HJ; Halank, M; Harbaum, L; Hennigs, JK; Heyckendorf, J; Klose, H; Lüneburg, N; Quast, G; Schulte-Hubbert, B; Sydow, K | 1 |
Gojakovic, BM; Jovanovic, DB; Jovanovic, NZ; Naumovic, RT; Simic-Ogrizovic, SP; Stanojevic-Stosovic, MLj; Stosović, MD | 1 |
Barros, H; Fraga, S; Guessous, I; Marques-Vidal, P; Paccaud, F; Stringhini, S; Vollenweider, P; Waeber, G | 1 |
Christ, SL; Friedman, EM; Mroczek, DK | 1 |
Cartwright, A; De Soyza, A; Eggleton, P; Hutchinson, D; Kelly, C; Perry, E; Quirke, AM; Venables, PJ | 1 |
Chen, A; DaDeppo, AJ; Hadley, HA; Kulin, W; LaWall, JS; MacFarland, FN; Matika, RW; Nielsen, VG; Steinbrenner, EB | 1 |
Caliskan, A; Demirtas, S; Kankilic, N; Karahan, O; Mavitas, B; Tezcan, O; Yavuz, C | 1 |
Kubilius, R; Mongirdienė, A | 1 |
Gao, M; Liu, Y; Longo, S; McGillis, S; Popescu, M; Wang, D; Zhao, LR | 1 |
Horii, M | 1 |
Kopec, AK; Luyendyk, JP | 1 |
Fernandes, T; Morris, T; Planquette, B; Sanchez, O | 1 |
Bohacekova, M; Kaldararova, M; Remkova, A; Simkova, I; Valkovicova, T; Vesely, J | 1 |
Hirschberg, R; Mitu, G | 1 |
Fehér, G; Horváth, B; Komoly, S; Márton, Z; Szapáry, L; Tóth, K | 1 |
Alyan, O; Demir, AD; Ilkay, E; Kacmaz, F; Karadede, A; Karahan, Z; Maden, O; Metin, F; Ozdemir, O; Topaloglu, S | 1 |
Thomas, NE; Williams, DR | 1 |
Acconcia, C; Angelino, A; Balsano, F; Di Girolamo, F; Diurni, V; Fravolini, F; Mancusi, C; Molfetta, R; Morelli, S | 1 |
Aragoncillo, I; de Vinuesa, SG; Goicoechea, M; Gómez-Campderá, F; Luño, J; Mosse, A; Verdalles, U | 1 |
Astor, BC; Bash, LD; Coresh, J; Erlinger, TP; Folsom, AR; Marsh-Manzi, J | 1 |
Rifkin, DE; Sarnak, MJ | 1 |
Holz, O; Kirsten, A; Kretschmar, G; Magnussen, H; Meyer, T; Müller, KC; Waschki, B; Watz, H | 1 |
Olu-Eddo, AN; Omoti, CE; Omuemu, CE | 1 |
Holak, EJ; Pagel, PS | 1 |
Guo, QX; Yu, J; Zhang, XM; Zhao, KQ | 1 |
Gibbs, S; Laffan, M; Szydlo, R; Wong, CL | 1 |
Lang, I | 1 |
Bauman, WA; Feldman, SP; Kahn, NN | 1 |
de Oliveira, C; Hamer, M; Watt, R | 1 |
Chen, Z; Hinohara, K; Inoue, Y; Kasahara, Y; Kimura, A; Nakajima, T; Sakao, S; Tanabe, N; Tatsumi, K | 1 |
Fujii, N; Hamano, T; Imai, E; Isaka, Y; Matsui, I; Mikami, S; Rakugi, H; Tomida, K | 1 |
Allen, K; Cantor, GH; Copple, BL; Guo, GL; Kassel, KM; Li, G; Luyendyk, JP | 1 |
Ahmed, M; Ghani, MH; Ghori, MA; Memon, MA; Mustafa, G; Siddiqui, SA | 1 |
Alifirova, VM; Vaizova, OE; Vengerovsky, AI | 1 |
Akilli, H; Alihanoglu, Y; Altunkeser, BB; Aribas, A; Ayhan, S; Can, I; Demir, K; Koc, F; Vatankulu, MA | 1 |
Foster, CS; Gonzalez-Gonzalez, LA; Mehta, M; Siddique, SS | 1 |
Kasahara, Y; Kodera, Y; Nomura, F; Sakao, S; Sogawa, K; Takiguchi, Y; Tanabe, N; Tatsumi, K; Umemura, H; Yano, T | 1 |
Brenner, B; Klein, E; Makhoul, B; Robicsek, O; Sarig, G | 1 |
Gornjakovic, S; Mesihovic, R; Prohic, D; Saray, A; Vanis, N | 1 |
Hirano, Y; Iwata, M; Kobayashi, M; Kubo, S; Ohtsu, Y; Shimizu, Y; Shiraki, K; Takahashi, K | 1 |
Jackowska, M; Kumari, M; Steptoe, A | 1 |
Adler, Y; Behar, S; Boyko, V; Goldbourt, U; Haim, M; Matetzky, S; Mekori, YA; Reshef, T; Tanne, D | 1 |
Balmer, H; Baumgartner, I; Do, DD; Mahler, F; Triller, J | 1 |
Bielański, W; Konturek, PC; Konturek, SJ; Kowalsky, M; Majka, J; Róg, T; Szczudlik, A | 1 |
Aranda, JL; Fernández-Miranda, C; Fuertes, A; Gómez De La Cámara, A; Paz, M | 1 |
Blann, AD; Chin, BS; Chung, NA; Gibbs, CR; Lip, GY | 1 |
Aguejouf, O; Doutremepuich, C; Doutremepuich, F; Mayo, K; Megraud, F; Monteiro, L | 1 |
Catalano, F; Cutrupi, S; Funahashi, T; Kihara, S; Mallamaci, F; Matsuzawa, Y; Ouchi, N; Panuccio, V; Parlongo, S; Tanaka, S; Tripepi, G; Zoccali, C | 1 |
Coward, PY; Crook, M; Ide, M; Lumb, P; McPartlin, D; Wilson, RF | 1 |
De Nardin, E; Genco, RJ; Sahingur, SE; Sharma, A | 1 |
Minagawa, T; Oda, H; Ohashi, H; Ohkuma, T; Ohno, M; Takada, N | 1 |
Borawski, J; Myśliwiec, M; Naumnik, B | 1 |
Barbieri, M; Mora, F; Mora, M; Mora, R; Yoo, TJ | 1 |
Kondashova, ZD; Nilova, TV | 1 |
Chen, J; Hamm, LL; He, J; Kusek, JW; Muntner, P; Whelton, PK | 1 |
Andreassen, AK; Aukrust, P; Gullestad, L; Hognestad, A; Holm, T; Kjekshus, JK; Semb, AG; Stokke, O; Wergeland, R | 1 |
Chang, H; Hung, CR; Wang, TL | 1 |
Copplestone, A; Gilbert, TJ; Haywood, GA; Jacob, K; Talwar, S | 1 |
Ikeda, T; Kobayashi, S; Kumagai, H; Moriya, H; Ohtake, T | 1 |
Alexy, T; Czopf, J; Demeter, N; Gaal, V; Horvath, B; Juricskay, I; Kesmarky, G; Klabuzai, A; Marton, Z; Szapary, L; Szots, M; Toth, K | 1 |
Block, P; De Backer, G; De Bacquer, D; Delanghe, J; Dendale, P; Verdaet, D | 1 |
Littler, WA; Shah, SU; White, A; White, S | 1 |
Marinello, J; Videla, S | 1 |
Channer, KS; English, KM; Jones, RD; Jones, TH; Malkin, CJ; Smith, AM | 1 |
Davenport, RJ | 1 |
Derevoedov, AA; Siurin, SA | 1 |
Jungers, P; Landais, P; Massy, ZA; Taupin, P | 1 |
Ohdo, M; Saniabadi, AR; Sawada, K; Shimoyama, T; Takahashi, R | 1 |
Dellepiane, M; Jankowska, B; Mora, F; Mora, R | 1 |
Hu, DY; Liu, MY | 1 |
Alexy, T; Czopf, I; Horvath, B; Kesmarky, G; Marton, Z; Nagy, F; Sapary, L; Toth, K; Zsots, M | 1 |
Cheung, AK; Chirananthavat, T; Leypoldt, JK; Mohammad, SF; Thekkedath, UR | 1 |
Burroughs, AK; Davidson, BR; Dhaliwal, P; Fusai, G; Patch, D; Rolando, N; Rolles, K; Sabin, CA | 1 |
Ayash, LJ; Braun, T; Ratanatharathorn, V; Reynolds, CM; Silver, SM; Uberti, JP | 1 |
Ahmed, AR; Anzaar, F; Bhol, K; Foster, CS; Letko, E; Perez, VL | 1 |
Abad, S; Cachofeiro, V; de Vinuesa, SG; Goicoechea, M; Gómez-Campderá, F; Lahera, V; Luño, J; Vega, A | 1 |
Frisbie, JH | 1 |
Anand, SC; Rajendran, S; Rigby, AJ | 1 |
Beddhu, S; Cheung, AK; Murtaugh, MA; Ramkumar, N | 1 |
Ademoglu, E; Cefle, K; Gokkusu, C; Guler, K; Ozturk, S; Palanduz, S; Tamer, S; Vatansever, S | 1 |
Choy, P; Gong, Y; Li, N; Li, P; Zu, N | 1 |
Altamura, N; Di Chiara, A; Fioretti, P; Fiotti, N; Giansante, C; Guarnieri, G; Wasserman, S | 1 |
Knight, B; Lim, R; Olynyk, JK; Yeoh, GC | 1 |
Clark, AL; Ford, SJ; Parker, JD; Preston, T; Witte, KK | 1 |
Coma-Canella, I; Martínez de Sizarrondo, S; Orbe, J; Páramo, JA; Rodríguez, JA; Serrano, R; Zudaire, M | 1 |
Elsayed, EF; Griffith, JL; Levey, AS; Salem, DN; Sarnak, MJ; Tighiouart, H; Weiner, DE | 1 |
Diez-Roux, AV; Heiss, G; Kaufman, JS; Pollitt, RA; Rose, KM; Zeng, D | 1 |
Branson, HE; Griffin, JH; Katz, J; Marble, R | 1 |
Jayson, MI; Keegan, A; Million, R; Tomlinson, I | 1 |
Dalakas, MC; Engel, WK | 1 |
Barsotti, G; Giovannetti, S; Lecchini, L; Panicucci, F; Pinori, E; Sagripanti, A; Vispi, M | 1 |
Takayama, S | 1 |
Alessandri, C; Cordova, C; Gnecchi, M; Iuliano, L; Musca, A; Perrone, A; Trinchieri, F; Violi, F | 1 |
Palamarchuk, VI | 1 |
Auriemma, L; Di Martino, G; Florio, A; Iannucci, F; Matarazzo, A; Rosati, V | 1 |
Dobrzanski, L; Joyner, R; Kreutzer, D; Lindsay, M; O'Rourke, J; Picciano, P; Rowland, F | 1 |
Kevorkov, NN; Tsimmerman, IaS; Vorona, TV | 1 |
Gordon, P; Weir, B | 1 |
Bodnar, PN | 1 |
Mattila, J | 1 |
Grundke-Iqbal, I; Lassmann, H; Wisniewski, HM | 1 |
Latorre, J; Marinello, J; Olba, L; Rosendo, A; Rutllant, ML; Sala Planell, E | 1 |
Bol'shakova, RM; Furkalo, NK; Kuts', VA; Progonnaia, VV; Romanenko, AI | 1 |
McKay, DG | 2 |
Barnes, T; Halle, P; Hoefs, J | 1 |
Haselager, EM; Vreeken, J | 1 |
Dormandy, JA | 1 |
Brusoni, V; Perego, M; Scotti, A; Turpini, R | 1 |
Armstrong, JD; Prescott, SM; Richards, KL; Shigeoka, JW; Tikoff, G | 1 |
Caimi, G; Catania, A; Francavilla, G; La Bruzzo, S; Romano, A; Sarno, A | 1 |
Ardaillou, N; Larrieu, MJ; Le Bras, P; Yvart, J | 1 |
Seki, Y; Shibata, A; Takahashi, H; Wada, K | 1 |
Bell, SA; Du Clos, TW; Khursigara, G; Picazo, JJ; Rubin, RL | 1 |
Chabanel, A; Razavian, M; Taccoen, A; Zuccarelli, F | 1 |
Dunn, FG; Lip, GY; Lowe, GD; Rumley, A | 1 |
Pósán, E; Tornai, I; Udvardy, M | 1 |
Carrington, D; Goggin, P; Leatham, E; Mendall, MA; Northfield, TC; Patel, P; Strachan, DP | 1 |
Fujisawa, H; Ito, H; Kashiwagi, S; Nakamura, K; Nomura, S | 1 |
Denis, J; Garrigues, JM; Gerentes, I; Taccoen, A; Trochet, JP | 1 |
Jaakkola, P; Laakso, M; Manninen, HI; Matsi, PJ | 1 |
Angelico, F; Giampaoli, S; Menotti, A; Morisi, G; Sotis, G; Urbinati, G | 1 |
Cucinell, S; Hathaway, TK; Steinbaum, SS | 1 |
Gourdin, FW; Smith, JG | 1 |
Beck, GJ; Comerota, AJ; Curl, GR; Ghosh, S; Graor, RA; Rao, AK; Ricotta, JJ; Skibinski, CI; Sun, L; Throm, RC | 1 |
Jantunen, E; Lahtinen, R; Neittaanmäki, H; Soppi, E | 1 |
Kelley, SD; Prager, MC; White, JD | 1 |
Engelbrecht, G; Hickman, R; Jaskiewicz, K; Kahn, D; Kirsch, RE; Robson, SC | 1 |
Ishizaki, A; Kawamura, A; Kukita, K; Meguro, J; Okano, M; Takahashi, M; Tamaki, T; Yanagida, N; Yonekawa, M | 1 |
Kustosz, J; Nowak, J; Raszeja-Specht, A; Rutkowski, B; Skibowska, A; Zdrojewski, Z | 1 |
Liu, HW; Qi, WS | 1 |
Blombäck, M; Bremme, K | 1 |
Małyszko, J; Małyszko, JS; Myśliwiec, M; Pawlak, K | 1 |
Kitadai, M; Satoh, K; Takahashi, T; Tsuda, Y | 1 |
Andres, A; Aranda, JL; Del Palacio, A; Fernandez-Miranda, C; Gomez-Gerique, J; Guijarro, C; Morales, JM; Porres, A; Rodicio, JL | 1 |
Luque Martín, JS; Mérida de la Torre, FJ; Morell Ocaña, M; Ortiz García, C; Rojano Martín, JC; Sánchez Luque, JJ | 1 |
Auer, DE; Kramer, H; Mills, PC; Ng, JC | 1 |
Erhard, J; Kabatnik, M; Peters, J; Scherer, R | 1 |
Gnarpe, H; Gnarpe, J; Lindahl, B; Siegbahn, A; Toss, H; Wallentin, L | 1 |
Kronenberg, F | 1 |
Friedman, EH | 1 |
Abbate, R; Attanasio, M; Bandinelli, B; Comeglio, M; Gensini, GF; Giusti, B; Gori, AM; Paniccia, R; Prisco, D; Serneri, GG | 1 |
Berman, L; Dolovich, J; Gibson, P; Gleich, GJ; Hargreave, FE; Parameswaran, K; Pizzichini, E; Pizzichini, MM | 1 |
Falkenhagen, D; Gerner, FJ; Linsberger, I; Schoenhofen, M; Schrefl, A; Strobl, W; Vogt, G | 1 |
Jousilahti, P; Rasi, V; Salomaa, V; Vahtera, E | 1 |
Arosio, C; Bertinieri, G; Blasi, F; Ceriani, G; Cosentini, R; Mandelli, C; Perondi, R; Ranzi, ML; Tarsia, P; Tien, TV; Torgano, G | 1 |
Piotrowski, Z; Puchalski, Z; Rucińska, M; Wojtukiewicz, MZ; Zimnoch, L | 1 |
Boyer, LV; Clark, RF; Dart, RC; McNally, JT; Nordt, SP; Seifert, SA; Walter, FG; Williams, SR | 1 |
Benvenuti, LA; Demarchi, LM; Higuchi, ML; Libby, P | 1 |
Dempfle, CE | 1 |
Abrignani, MG; Braschi, A; Braschi, GB; Caruso, R; Di Girolamo, A; Novo, G; Novo, S; Strano, A; Tantillo, R | 1 |
Azaceta, G; Azcona, JM; Gutiérrez, M; Lorente, C; Moreno, JA; Olave, T; Romero, S; Vaquerizo, A | 1 |
Blann, AD; Li-Saw-Hee, FL; Lip, GY | 2 |
Kendić, S; Mujezinović, O; Muratović, H | 1 |
Hetzel, J; Hoffmeister, A; Hombach, V; Koenig, W; Kron, M; Sander, S | 1 |
Blann, AD; Foo, LS; Goldsmith, IR; Lip, GY | 1 |
Brunner, KG; Buckley, PJ; Burchell, LJ; Dong, Y; Fechner, JH; Hamawy, MM; Hong, X; Knechtle, SJ; Lagoo, AS; Oberley, TD; Peters, D; Tsuchida, M | 1 |
Agricola, E; Ammaturo, T; Barbati, R; Fineschi, D; Guerrini, F; Mondillo, S; Nami, R; Pastore, M; Sabatini, L | 1 |
Evans, N; Grant, BJ; Klingman, KL; Murphy, TF; Muscarella, K; Sethi, S | 1 |
Blann, AD; Gibbs, CR; Lip, GY; Watson, RD | 1 |
Kristensson, K; Mhlanga, JD; Mulenga, C; Robertson, B | 1 |
Jagodziński, P; Lizakowski, S; Rutkowski, B; Słomińska, E; Zdrojewski, Z | 1 |
Blann, AD; Edmunds, E; Gibbs, CR; Li-Saw-Hee, FL; Lip, GY | 1 |
Al-Saady, NM; Sopher, M | 1 |
Blann, AD; Gurney, D; Li-Saw-Hee, FL; Lip, GY | 1 |
Honda, S; Kashiwagi, H; Kato, H; Kiyoi, T; Kosugi, S; Kurata, Y; Matsuzawa, Y; Tomiyama, Y | 1 |
Drouin, P; Duriez, P; Fruchart, JC; Guerci, B; Quilliot, D; Walters, E; Ziegler, O | 1 |
Dahl, M; Lange, P; Nordestgaard, BG; Tybjaerg-Hansen, A; Vestbo, J | 1 |
D'Agostino, R; Festa, A; Haffner, SM; Karter, AJ; Mayer-Davis, EJ; Tracy, RP; Williams, K | 1 |
Nilova, TV; Zvenigorodskaia, LA | 1 |
Akerström, B; Falkenberg, C; Holmdahl, R; Larsson, A; Nordquist, N; Olofsson, P; Pettersson, U; Vingsbo-Lundberg, C | 1 |
Altman, R; Gonzalez, C; Rouvier, J; Scazziota, A | 1 |
Altamura, N; Di Chiara, A; Fioretti, P; Fiotti, N; Giansante, C; Guarnieri, G; Miccio, M | 1 |
Almér, LO; Nilsson, IM; Pandolfi, M | 1 |
Ito, H; Komai, T; Mizukoshi, H; Yamamoto, S | 1 |
Heidrich, R; Hindersin, P | 1 |
Dymock, IW; Green, G; Poller, L; Thomson, JM | 2 |
Lechner, K; Niessner, H; Thaler, E | 1 |
Kalsbeek, GL; Nieboer, C; Roeleveld, CG | 1 |
Kawai, C; Nagai, T | 1 |
Faulk, WP; Fudenberg, HH; Hughson, HD; McManus, JF; Patrick, CC; Virella, G | 1 |
Kawai, C; Nagai, T; Tamura, T | 1 |
Skrifvars, B | 1 |
Fedorishko, SS; Palamarchuk, VI; Revutskiĭ, EL; Vendt, VP | 1 |
Aledort, LM | 1 |
Fedorishko, SS; Palamarchuk, VI | 1 |
Christensen, KD | 1 |
Bowie, EJ; Owen, CA | 2 |
Di Perri, T; Forconi, S; Guerrini, M; Pecchi, S; Rossi, C | 1 |
Frezza, M; Gilotta, S; Milani, S; Nicolini, R; Pozzato, G; Valente, G | 1 |
Chibireva, EM; Emel'kin, VI; Pertsovskiĭ, AI | 1 |
Kakkar, VV; Lane, DA; Scully, MF; Thomas, DP; Williams, R; Woolf, IL | 1 |
Barr, RD; Carty, MJ; Ouna, N | 1 |
Ball, GV; Goldman, LN | 1 |
Friedman, SA | 1 |
Olszańska-Skorek, T | 1 |
Hasegawa, H; Murao, M; Nagata, H; Watanabe, N | 1 |
Khurshid, M; Whittaker, JA | 1 |
Martin, DC; Nellans, R; Otis, P | 1 |
Bloom, AL | 1 |
Gavrilova, RD; Surovikina, MS | 1 |
Ehrly, AM | 2 |
Kochen, M; Leonhardt, H; Palme, G | 1 |
Bisztyga, A; Brajerski, W; Ilenda, M; Sikorska, K | 1 |
Dreiling, DA; Tuzhilin, DA | 1 |
Clark, RD; Flute, PT; Gazzard, BG; Lewis, ML; Williams, R | 1 |
Guriev, SB; Irgashev, SB; Koteliansky, VE; Shekhonin, BV | 1 |
Blanke, H; Höffken, H; Leschke, M; Motz, W; Schöbel, F; Strauer, BE | 1 |
Shi, JZ; Wang, QM | 1 |
Kawashima, M; Suzuki, H; Tamura, K; Tohgi, H | 1 |
Drannik, GN; Ukhal', MI | 1 |
Arbes, H; Bösch, P; Lack, W | 1 |
Champsaur, G; Cochet, P; Ninet, J; Risk, M; Thevenet, F; Vigneron, M | 1 |
Brauneis, J; Laskawi, R; Shröder, J | 1 |
Allardyce, M; Barr, RD; Brunt, PW; McIntire, KR; Usher, DJ | 1 |
Fleming, AW; Kram, HB; Nathan, RC; Shoemaker, WC; Stafford, FJ | 1 |
Abiko, S; Aoki, H; Harada, K; Orita, T | 1 |
Gotoh, F; Mihara, B; Nara, M; Ohta, K; Shinohara, T; Tanahashi, N; Terayama, Y; Tomita, M | 1 |
Hartleb, M; Kacperek, T; Nowak, A | 1 |
Boccuzzi, A; Carrieri, PB; Ciliberti, C; Liguori, T; Lombardo, A; Orefice, G; Patitucci, R | 1 |
Ciuffetti, G; Lombardini, R; Mercuri, M; Palazzetti, D; Paltriccia, R; Parnetti, L; Savastano, V; Scarponi, AM | 1 |
Alegre, VA; Aliaga, A; Winkelmann, RK | 1 |
Fiorini, G; Gagliano, MG; Gibelli, A; Motta, A; Toschi, V | 1 |
Gulland, FM; Hawkey, CM | 1 |
Nechaev, VI | 1 |
Inoue, W; Miura, M; Nomoto, Y; Sakai, H; Tamura, S; Tomino, Y; Yagame, M | 1 |
Girolami, A; Mares, M; Patrassi, GM; Piermarocchi, S; Santarossa, A; Viero, M | 1 |
Blümel, G; Graeff, H; Hafter, R; Trappe, A; Wendt, P | 1 |
Malchesky, PS; Nose, Y; Okabe, K; Sakamoto, H; Smith, JW; Takaoka, T; Tuthill, RJ; Usami, M | 1 |
Gschrey, G; Haid, T | 1 |
Bernardo, B; Bertone, L; Bracale, G; De Caterina, M; Scalise, E; Selvetella, L | 1 |
Browse, NL; Leach, RD | 1 |
Murashko, VV; Shabashova, NI; Shylle, ChI; Skliarova, MA; Zhuravlev, AK | 1 |
Inoue, W; Itoh, K; Miura, M; Nomoto, Y; Sakai, H; Tamura, S; Tomino, Y | 1 |
Young, JR | 1 |
Brunt, PW; Mowat, NA; Ogston, D | 1 |
Colman, RW; Mosesson, MW; Sherry, S | 1 |
Gautier, J; Ginies, G; Lamisse, F | 1 |
Hadlich, J | 1 |
Ito, T; Matsui, E; Niwa, T | 1 |
Ambrus, CM; Ambrus, JL; Baliah, T; Mink, IB; Murphy, GP | 1 |
Heyes, H; Hiemeyer, V; Hilgard, P; Sigmund, E | 1 |
Czarniecki, W; Filipowicz, Z; Kardasiewicz, W; Malanowicz, W; Schreyer, K | 1 |
Fomicheva, NI | 1 |
Woszczyk, J | 1 |
Amor, H; Braunsteiner, H; Holzknecht, F; Hörtnagl, H; Kunz, F; Weiser, G | 1 |
Blomhoff, JP; Gjone, E; Ritland, S; Skrede, S | 1 |
Kreuning, J; Veltkamp, JJ | 1 |
Coccheri, S; Gasbarrini, G | 1 |
De Gaetano, G; Donati, MB; Dotremont, G; Vermylen, J; Verstraete, M | 1 |
Czarniecki, W | 1 |
Gerrits, WB; van Aken, WG; van der Meer, J; Vreeken, J | 1 |
Bürgi, H | 2 |
Hrubisková, K | 1 |
Bennich, H; Bergquist, NR; Bergstrand, A; Bergström, J; Johansson, SG; Wasserman, J | 1 |
Hackel, F; Voigt, H; Wiemers, U | 1 |
Yoshizawa, N | 1 |
Ryff, IM; Sokolova, RI; Zhigalkin, GV | 1 |
Bazaz'ian, GG; Kudriashov, BA; Liapina, LP | 1 |
Matsuda, T | 1 |
Pierce, LE | 1 |
Penner, JA; Schnetzer, GW | 1 |
Bolocan, T; Grecu, O; Păunescu-Podeanu, A | 1 |
Bromberg-Sznek, S; Palester-Chlebowczyk, M; Strzyzewska, E; Vertun, B; Wolańska, A | 1 |
Wardle, EN | 1 |
Zöller, H | 1 |
Avioli, LV; Sherman, LA; Wessler, S | 1 |
Scrobohaci, ML; Stăncioiu, N | 1 |
Conard, J; Samama, M | 1 |
Straub, PW | 2 |
Connolly, JE; Gazzaniga, AB | 1 |
Konstantinov, VV | 1 |
Perron, L; Thuot, C | 1 |
Harkness, J | 1 |
Buergi, H; Medici, TC | 1 |
Whelton, MJ | 1 |
Bläker, F; Bünger, P; Elema, JD; Henningsen, B; Maintz, J | 1 |
Balis, MS; Epstein, WV | 1 |
Karaca, M; Nilsson, IM | 1 |
Dorofeeva, RP; Safonova, LG | 1 |
Domula, M; Lenk, H; Weissbach, G | 1 |
Drevina, AI; Grinshteĭn, EIa | 1 |
Osmanova, PG | 1 |
Berezhnitskiĭ, MN; Shvedenko, LA; Vakaliuk, PM | 1 |
Komarova, IA | 1 |
Bowie, EJ; Didisheim, P; Oels, HC; Owen, CA; Thompson, JH | 1 |
Antoine, B; Debray-Sachs, M; Gourdin, MF; Patte, D | 1 |
Cain, GD; Jones, EA; Mayer, G | 1 |
Hall, GH; Holman, HM; Webster, AD | 1 |
de Gaetano, G; Donati, MB; Dotremont, G; Michielsen, P; Vermylen, J | 1 |
Nitzschner, HH | 1 |
Chernysheva, GV | 1 |
Chistov, AG; Pilipenko, VZ; Trubinkov, AM | 1 |
Voprontsova, GV | 1 |
Lee, LC; Owen, CA; Sauer, WG; Spittell, JA; Thompson, JH | 1 |
Bielawiec, M; Lukjan, H | 1 |
Brackenridge, CJ; Jones, IH | 1 |
Feniuk, EV | 1 |
Belozovskaia, EB; Bezrodnykh, AA; Chebotarev, AG | 1 |
Ashkinazi, IIa | 1 |
Göltner, E; Mingers, A; Pavel, W; Scheitza, E; Ströder, J | 1 |
Riabinin, IF | 1 |
22 review(s) available for fibrinogen and Chronic Disease
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Childhood socioeconomic status and inflammation: A systematic review and meta-analysis.
Topics: Adolescent; Adult; Adverse Childhood Experiences; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Child; Chronic Disease; Female; Fibrinogen; Humans; Income; Inflammation; Interleukin-6; Longitudinal Studies; Male; Risk Factors; Social Class; Socioeconomic Factors; Stress, Psychological | 2019 |
Role of Fibrin(ogen) in Progression of Liver Disease: Guilt by Association?
Topics: Acute Disease; Animals; Chronic Disease; Disease Models, Animal; Fibrin; Fibrinogen; Humans; Liver Diseases; Mice | 2016 |
From Acute to Chronic Thromboembolic Disease.
Topics: Acute Disease; Chronic Disease; Endarterectomy; Fibrinogen; Hemodynamics; Humans; Hypertension, Pulmonary; Pulmonary Artery; Pulmonary Embolism; Risk Factors; Thrombolytic Therapy; Vascular Remodeling; Venous Thromboembolism | 2016 |
Bone morphogenetic protein-7 (BMP7) in chronic kidney disease.
Topics: Bone Morphogenetic Protein 3; Bone Morphogenetic Protein 7; Bone Morphogenetic Protein Receptors; Bone Morphogenetic Proteins; Chronic Disease; Diabetic Nephropathies; Fibrinogen; Gene Expression Regulation; Humans; Inhibins; Kidney; Kidney Diseases; Renal Insufficiency; Transforming Growth Factor beta | 2008 |
Inflammatory factors, physical activity, and physical fitness in young people.
Topics: Adolescent; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Child; Child, Preschool; Chronic Disease; Energy Metabolism; Exercise; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Motor Activity; Obesity; Oxygen Consumption; Physical Fitness; Young Adult | 2008 |
Advances in understanding the pathogenesis of chronic thromboembolic pulmonary hypertension.
Topics: Chronic Disease; Endarterectomy; Fibrinogen; Fibrinolysis; Humans; Hypertension, Pulmonary; Pulmonary Embolism; Venous Thromboembolism | 2010 |
Heart and mind: (1) relationship between cardiovascular and psychiatric conditions.
Topics: Acute Disease; Anxiety; Arrhythmias, Cardiac; Blood Platelet Disorders; Cardiovascular Diseases; Chronic Disease; Fibrinogen; Humans; Mental Disorders; Neurosecretory Systems; Stress, Psychological | 2004 |
Venous leg ulcer treatment and practice--part 1: the causes and diagnosis of venous leg ulcers.
Topics: Blood Flow Velocity; Capillaries; Causality; Chronic Disease; Fibrinogen; Humans; Incidence; Leukocytes; Microcirculation; Phlebography; Photoplethysmography; Ultrasonography, Doppler; Ultrasonography, Doppler, Duplex; Varicose Ulcer | 2007 |
Etiology of venous ulceration.
Topics: Capillary Permeability; Cell Hypoxia; Chronic Disease; Fibrin; Fibrinogen; Humans; Hypertension; Leg Ulcer; Leukocytes; Microcirculation; Necrosis; Terminology as Topic; Thrombosis; Venous Insufficiency; Venous Pressure | 1993 |
[Progress in the studies on traditional Chinese medicine syndrome differentiation of chronic glomerulonephritis with laboratory findings].
Topics: Chronic Disease; Diagnosis, Differential; Fibrinogen; Glomerulonephritis; Humans; Medicine, Chinese Traditional; Yang Deficiency | 1996 |
Homocysteine, lipoprotein(a) and fibrinogen: metabolic risk factors for cardiovascular complications of chronic renal disease.
Topics: Arteriosclerosis; Cardiovascular Diseases; Chronic Disease; Fibrinogen; Folic Acid; Homocysteine; Humans; Kidney Diseases; Lipoprotein(a); Risk Factors | 1998 |
The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
Topics: Acute Disease; Animals; Blood Coagulation; Chronic Disease; Disseminated Intravascular Coagulation; Epitopes; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Plasminogen; Thrombophilia; Venous Thrombosis | 1999 |
Intravascular coagulation and the liver.
Topics: Acute Disease; Chronic Disease; Erythrocyte Aggregation; Factor VIII; Fibrinogen; Heparin; Humans; Liver Diseases; Liver Extracts | 1975 |
Participation of components of the blood coagulation system in the inflammatory response.
Topics: Arthritis; Blood Coagulation Factors; Blood Platelets; Chronic Disease; Complement System Proteins; Connective Tissue; Disseminated Intravascular Coagulation; Endotoxins; Factor XII; Fibrin; Fibrinogen; Fibrinolysin; Glomerulonephritis; Humans; Inflammation; Kinins; Leukocytes; Nephritis; Shwartzman Phenomenon | 1972 |
Fibrin-fibrinogen degradation products in children with renal disease.
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Female; Fibrin; Fibrinogen; Glomerulonephritis; Hemolytic-Uremic Syndrome; Humans; Immune Complex Diseases; Immunoglobulin A; Immunoglobulin G; Kidney Diseases; Lupus Erythematosus, Systemic; Male; Middle Aged; Nephritis; Nephrosis; Nephrotic Syndrome; Purpura; Streptococcal Infections | 1974 |
[Significance of determination of fibrin and fibrinogen degradation products].
Topics: Acute Disease; Blood Coagulation Disorders; Blood Coagulation Tests; Chronic Disease; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Fibrinolysis; Graft Rejection; Humans; Kidney; Kidney Transplantation; Male; Pregnancy; Time Factors; Transplantation, Homologous | 1972 |
[Intravascular coagulation and degradation products of fibrinogen and fibrin. (Review of new findings and diagnostic possibilities].
Topics: Blood Coagulation; Burns; Chronic Disease; Disseminated Intravascular Coagulation; Factor V; Factor VIII; Fibrin; Fibrinogen; Fibrinolysis; Hemagglutination Tests; Hemostasis; Humans; Leukemia; Purpura, Thrombotic Thrombocytopenic; Thrombin | 1974 |
[Diagnosis and follow-up control of peripheral vein diseases].
Topics: Acute Disease; Chronic Disease; Fibrinogen; Follow-Up Studies; Humans; Iodine Radioisotopes; Pain; Palpation; Phlebography; Photography; Plethysmography; Thermography; Thrombophlebitis; Tourniquets; Ultrasonography; Varicose Veins; Venous Insufficiency; Venous Pressure | 1974 |
Chronic intravascular coagulation syndromes. A summary.
Topics: Blood Coagulation; Bone Marrow; Chronic Disease; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Humans; Liver; Lung Neoplasms; Male; Prostatic Neoplasms; Surgical Procedures, Operative | 1974 |
[Complement and the immune system in chronic glomerulonephritis].
Topics: Antigen-Antibody Complex; Basement Membrane; Blood Coagulation; Chronic Disease; Complement System Proteins; Fibrinogen; Glomerulonephritis; Humans; Immunity, Cellular; Kidney; Kidney Glomerulus; Lymphocytes | 1974 |
The viscosity of human blood plasma; its measurement in health and disease.
Topics: Acute Disease; Adult; Age Factors; Anticoagulants; Blood Protein Disorders; Blood Proteins; Blood Viscosity; Chronic Disease; Circadian Rhythm; Diagnosis; Female; Fibrinogen; Humans; Infant, Newborn; Male; Methods; Neoplasms; Physical Exertion; Plasma; Pregnancy; Rheology; Serum Albumin; Serum Globulins; Sex Factors; Temperature | 1971 |
31 trial(s) available for fibrinogen and Chronic Disease
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Markers of Inflammation and Incident Breast Cancer Risk in the Women's Health Study.
Topics: Age Factors; Aged; Biomarkers; Body Mass Index; Breast Neoplasms; C-Reactive Protein; Chronic Disease; Female; Fibrinogen; Health Behavior; Humans; Inflammation; Inflammation Mediators; Intercellular Adhesion Molecule-1; Middle Aged; Neoplasm Invasiveness; Proportional Hazards Models; Risk Factors; Women's Health | 2018 |
[Clinical efficacy and safety of sequential treatment with alprostadil and beraprost sodium for chronic renal failure induced by chronic glomerulonephritis].
Topics: Adolescent; Adult; Aged; Alprostadil; Blood Urea Nitrogen; Chronic Disease; Creatinine; Drug Therapy, Combination; Epoprostenol; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Glomerular Filtration Rate; Glomerulonephritis; Humans; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Prothrombin Time; Urological Agents; Young Adult | 2013 |
Atorvastatin given prior to electrical cardioversion does not affect the recurrence of atrial fibrillation in patients with persistent atrial fibrillation who are on antiarrhythmic therapy.
Topics: Analysis of Variance; Anti-Arrhythmia Agents; Anticholesteremic Agents; Anticoagulants; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Chronic Disease; Electric Countershock; Female; Fibrinogen; Health Status Indicators; Heptanoic Acids; Humans; Leukocyte Count; Male; Middle Aged; Pyrroles; Secondary Prevention; Time Factors; Warfarin | 2011 |
Serum level of fibrinogen Aα chain fragment increases in chronic thromboembolic pulmonary hypertension.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Female; Fibrinogen; Humans; Hypertension, Pulmonary; Male; Middle Aged; Peptides; Pulmonary Embolism; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2011 |
Effect of treatment of chronic periodontitis on levels of serum markers of acute-phase inflammatory and vascular responses.
Topics: Acute-Phase Proteins; Adult; Analysis of Variance; Biomarkers; C-Reactive Protein; Chronic Disease; Cohort Studies; Dental Plaque Index; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation Mediators; Interleukin-1; Interleukin-6; Male; Matched-Pair Analysis; Middle Aged; N-Acetylneuraminic Acid; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Prospective Studies; Tumor Necrosis Factor-alpha | 2003 |
Intravenous infusion of recombinant tissue plasminogen activator for the treatment of patients with sudden and/or chronic hearing loss.
Topics: Age Factors; Analysis of Variance; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Feasibility Studies; Fibrinogen; Fibrinolytic Agents; Hearing Loss; Hearing Loss, Sudden; Humans; Infusions, Intravenous; Middle Aged; Prothrombin; Regression Analysis; Tissue Plasminogen Activator | 2003 |
Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation.
Topics: Arteriosclerosis; Atorvastatin; C-Reactive Protein; Chronic Disease; Coronary Artery Disease; E-Selectin; Female; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Nitric Oxide; Pyrroles; Simvastatin; Treatment Outcome | 2004 |
Chronic venous insufficiency of the lower limbs: suitability of transcutaneous blood gas monitoring as an endpoint to evaluate the outcome of pharmacological treatment with calcium dobesilate.
Topics: Adolescent; Adult; Aged; Blood Gas Monitoring, Transcutaneous; Calcium Dobesilate; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Fibrinogen; Humans; Leg; Male; Middle Aged; Pain Measurement; Pilot Projects; Plethysmography; Treatment Outcome; Venous Insufficiency | 2004 |
Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina.
Topics: Administration, Cutaneous; Androgens; Angina Pectoris; Blood Coagulation; Chronic Disease; Fibrinogen; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors; Testosterone; Thrombosis; Tissue Plasminogen Activator | 2005 |
The use of recombinant tissue-type plasminogen activator for the treatment of sudden and chronic hearing loss.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Cochlea; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fibrinogen; Fibrinolytic Agents; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Infusions, Intravenous; Male; Middle Aged; Prothrombin; Tissue Plasminogen Activator; Treatment Outcome | 2005 |
Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa.
Topics: Aged; Aged, 80 and over; Binding, Competitive; Blood Platelets; Chromatography, Affinity; Chronic Disease; Fibrinogen; Flow Cytometry; Gene Expression Regulation; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Renal Dialysis; Uremia | 2006 |
Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk acute myelogenous leukemia.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chronic Disease; Disease-Free Survival; Doxorubicin; Factor XIII; Female; Fibrinogen; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Thrombin; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous | 2007 |
Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.
Topics: Aged; Aged, 80 and over; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Chronic Disease; Dose-Response Relationship, Drug; Dyslipidemias; Female; Fibrinogen; Fibrinolysis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-6; Kidney Diseases; Lipid Metabolism; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prospective Studies; Pyrroles; Tissue Plasminogen Activator | 2006 |
Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
Topics: Adult; Aged; Atrial Fibrillation; Biomarkers; Chronic Disease; Cross-Sectional Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Longitudinal Studies; Male; Middle Aged; Thrombosis; von Willebrand Factor; Warfarin | 1995 |
[Rheological parameters in hemorrhoid pathology].
Topics: Acute Disease; Adult; Aged; Chronic Disease; Erythrocyte Aggregation; Female; Fibrinogen; Gastrointestinal Hemorrhage; Hemorheology; Hemorrhoids; Humans; Male; Middle Aged; Prolapse; Regional Blood Flow; Thrombosis | 1994 |
Effects of cryoprecipitate on the healing of chronic wounds.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Double-Blind Method; Factor VIII; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Wound Healing; Wounds and Injuries | 1994 |
A prospective, randomized, blinded, and placebo-controlled trial of intraoperative intra-arterial urokinase infusion during lower extremity revascularization. Regional and systemic effects.
Topics: Aged; Chronic Disease; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Fibrinogen; Humans; Infusions, Intra-Arterial; Intraoperative Care; Ischemia; Leg; Male; Middle Aged; Plasminogen; Postoperative Complications; Prospective Studies; Single-Blind Method; Urokinase-Type Plasminogen Activator | 1993 |
Availability of cryofiltration in renal transplantation.
Topics: Adult; Chronic Disease; Female; Fibrinogen; Fibronectins; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Kidney Transplantation; Leukapheresis; Male; Ultrafiltration | 1996 |
[Evaluation of platelet membrane structure in patients with chronic glomerulonephritis (CGN)].
Topics: Adult; Blood Platelets; Cell Membrane; Chronic Disease; Electron Spin Resonance Spectroscopy; Female; Fibrinogen; Glomerulonephritis; Humans; Lipid Bilayers; Male; Middle Aged; Phospholipids; Platelet Aggregation; Spin Labels; Triglycerides | 1996 |
Hemorheologic profiles of plasma fibrinogen and blood viscosity from silent to acute and chronic cerebral infarctions.
Topics: Acute Disease; Aged; Blood Viscosity; Cerebral Infarction; Cerebrovascular Disorders; Chronic Disease; Female; Fibrinogen; Hemorheology; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Risk Factors; Statistics, Nonparametric | 1997 |
The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease.
Topics: Adult; Antithrombin III; Blood Coagulation; Chronic Disease; Dose-Response Relationship, Drug; Female; Fibrinogen; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Partial Thromboplastin Time; Prospective Studies; Prothrombin Time; Serine Proteinase Inhibitors | 1997 |
Effect of low-dose heparin on fibrinogen levels in patients with chronic ischemic heart disease.
Topics: Aged; Anticoagulants; Antithrombin III; Chronic Disease; Cross-Over Studies; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Male; Middle Aged; Myocardial Ischemia; Peptide Fragments; Peptide Hydrolases; Protein Precursors; Prothrombin; Thrombin | 1998 |
Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Blood Proteins; Bronchitis; Chronic Disease; Cross-Over Studies; Dyspnea; Eosinophil Granule Proteins; Eosinophilia; Female; Fibrinogen; Follow-Up Studies; Forced Expiratory Volume; Forecasting; Glucocorticoids; Humans; Inflammation Mediators; Male; Middle Aged; Placebos; Prednisone; Quality of Life; Reproducibility of Results; Ribonucleases; Single-Blind Method; Smoking; Sputum | 1998 |
Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Chlamydia Infections; Chlamydophila pneumoniae; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Omeprazole; Risk Factors; Tinidazole | 1999 |
Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Dose-Response Relationship, Drug; Drug Combinations; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Aggregation Inhibitors; Prospective Studies; Reference Values; Thrombosis; von Willebrand Factor; Warfarin | 2000 |
Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Arrhythmia, Sinus; Blood Platelets; Chronic Disease; Cohort Studies; Cross-Sectional Studies; Endothelium, Vascular; Female; Fibrinogen; Heart Diseases; Hematocrit; Humans; Lisinopril; Male; Middle Aged; P-Selectin; Platelet Count; Regression Analysis; Rheology; Sex Characteristics; Solubility; Statistics, Nonparametric; Viscosity; von Willebrand Factor | 2001 |
[The concentration of adenine nucleotides in platelets of patients with primary chronic glomerulonephritis].
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Adult; Blood Platelets; Cholesterol; Cholesterol, LDL; Chromatography, High Pressure Liquid; Chronic Disease; Female; Fibrinogen; Glomerulonephritis; Humans; Male; Middle Aged; Nephrotic Syndrome; Platelet Activation; Serum Albumin; Triglycerides | 2000 |
Effect of the inflammation, chronic hyperglycemia, or malabsorption on the apolipoprotein A-IV concentration in type 1 diabetes mellitus and in diabetes secondary to chronic pancreatitis.
Topics: Adult; Apolipoproteins A; Biomarkers; Blood Glucose; Ceruloplasmin; Chronic Disease; Diabetes Mellitus, Type 1; Dietary Fats; Fibrinogen; Glycated Hemoglobin; Haptoglobins; Humans; Hyperglycemia; Inflammation; Linear Models; Malabsorption Syndromes; Male; Middle Aged; Pancreatitis; Predictive Value of Tests | 2001 |
Treatment of seronegative spondylarthritis with levamisole: a double-blind placebo-controlled study.
Topics: Adult; Arthritis; Blood Sedimentation; Chronic Disease; Double-Blind Method; Female; Fibrinogen; Humans; Levamisole; Male; Spondylitis, Ankylosing | 1979 |
[Value in pulmonary diseases of a new broad spectrum semi-synthetic penicillin: amoxicillin].
Topics: Amines; Ampicillin; Bacteria; Bacterial Infections; Bronchi; Bronchitis; Cephalosporins; Chloramphenicol; Chronic Disease; Clinical Trials as Topic; DNA; Fibrinogen; Humans; L-Lactate Dehydrogenase; Leukocyte Count; Mucus; Penicillins; Recurrence; Respiratory Tract Infections; Saliva; Tetracycline | 1973 |
278 other study(ies) available for fibrinogen and Chronic Disease
Article | Year |
---|---|
The erythrocyte sedimentation rate (ESR) in canine inflammation.
Topics: Animals; Biomarkers; Blood Sedimentation; C-Reactive Protein; Chronic Disease; Dog Diseases; Dogs; Fibrinogen; Inflammation; Prospective Studies; Retrospective Studies | 2023 |
Effect of Microecological Regulator Combined with Enteral Nutrition on Immune and Coagulation Function in Patients with Chronic Critical Illness.
Topics: Blood Coagulation; Chronic Disease; Critical Illness; Enteral Nutrition; Fibrinogen; Humans | 2023 |
Unexpected low expression of platelet fibrinogen receptor in patients with chronic myeloproliferative neoplasms: how does it change with aspirin?
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Platelets; Chronic Disease; Fibrinogen; Humans; Middle Aged; Myeloproliferative Disorders | 2020 |
The effect of smoking on chronic inflammation, immune function and blood cell composition.
Topics: Adaptive Immunity; Aged; Biomarkers; Blood Cell Count; C-Reactive Protein; Carcinoembryonic Antigen; Chronic Disease; Cytokines; Female; Fibrinogen; Humans; Immunity, Innate; Inflammation; Interleukin-6; Male; Middle Aged; Smoking | 2020 |
Presence of nucleosomes in plasma and increased thrombin generation in dogs with acute and chronic gastroenteropathies.
Topics: Animals; Chronic Disease; Dog Diseases; Dogs; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Gastroenteritis; Lymphoma; Male; Nucleosomes; Prospective Studies; Thrombin; Thrombophilia | 2021 |
Low-grade chronic inflammation and immune alterations in childhood and adolescent cancer survivors: A contribution to accelerated aging?
Topics: Adaptive Immunity; Adolescent; ADP-ribosyl Cyclase 1; Age Factors; Aging; Biomarkers; C-Reactive Protein; Cancer Survivors; Case-Control Studies; Cellular Senescence; Child; Chronic Disease; Female; Fibrinogen; Humans; Inflammation; Machine Learning; Male; Membrane Glycoproteins; T-Lymphocytes; Young Adult | 2021 |
Serum Soluble Fibrinogen-Like Protein 2 Represents a Novel Biomarker for Differentiation Between Acute and Chronic Egyptian Hepatitis B Virus-Infected Patients.
Topics: Acute Disease; Biomarkers; Chronic Disease; Egypt; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Hepatitis B, Chronic; Humans; Male; Middle Aged | 2021 |
CRP, D-dimer, fibrinogen and ESR as predictive markers of response to standard doses of levocetirizine in patients with chronic spontaneous urticaria.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Sedimentation; C-Reactive Protein; Cetirizine; Chronic Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Histamine H1 Antagonists, Non-Sedating; Humans; Immunoglobulin E; Inflammation Mediators; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Quality of Life; Severity of Illness Index; Time Factors; Treatment Outcome; Urticaria; Young Adult | 2017 |
Individual serum saturated fatty acids and markers of chronic subclinical inflammation: the Insulin Resistance Atherosclerosis Study.
Topics: Adult; Aged; Atherosclerosis; Biomarkers; Chronic Disease; Cross-Sectional Studies; Fatty Acids; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Insulin Resistance; Male; Middle Aged; Plasminogen Activator Inhibitor 1 | 2017 |
Highly multiplexed proteomic analysis reveals significant tissue and exosomal coagulation pathway derangement in chronic rhinosinusitis with nasal polyps.
Topics: Adult; Blood Coagulation; Blood Coagulation Disorders; Chronic Disease; Exosomes; Female; Fibrinogen; Fibronectins; Humans; Male; Middle Aged; Mucus; Nasal Polyps; Proteomics; Rhinitis; Sinusitis; Up-Regulation; von Willebrand Factor | 2018 |
Impaired frequencies and function of platelets and tissue remodeling in chronic Chagas disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Platelets; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Endothelin-1; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; P-Selectin; Procollagen; Trypanosoma cruzi; Young Adult | 2019 |
Associations between Dietary Inflammatory Index Scores and Inflammatory Biomarkers among Older Adults in the Lothian Birth Cohort 1936 Study.
Topics: Aged; Aged, 80 and over; Biomarkers; Body Mass Index; C-Reactive Protein; Chronic Disease; Cohort Studies; Cross-Sectional Studies; Diet; Exercise; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Logistic Models; Male; Scotland; Surveys and Questionnaires | 2019 |
Fibrinogen Aα Thr312Ala polymorphism specifically contributes to chronic thromboembolic pulmonary hypertension by increasing fibrin resistance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Fibrin; Fibrinogen; Fibrinolysis; Gene Frequency; Genotype; Humans; Hypertension, Pulmonary; Male; Middle Aged; Polymorphism, Single Nucleotide; Pulmonary Embolism; Young Adult | 2013 |
Effects of acute and chronic psychological stress on platelet aggregation in mice.
Topics: Acute Disease; Adrenalectomy; Animals; Body Weight; Calcium Signaling; Chronic Disease; Drinking Behavior; Feeding Behavior; Fibrinogen; Male; Mice; Pituitary-Adrenal System; Platelet Aggregation; Random Allocation; Restraint, Physical; Stress, Psychological; Thrombin; Transportation | 2014 |
Relationship between physical activity and plasma fibrinogen concentrations in adults without chronic diseases.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Cross-Sectional Studies; Exercise; Female; Fibrinogen; Follow-Up Studies; Healthy Volunteers; Humans; Male; Middle Aged; Prognosis; Young Adult | 2014 |
Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile.
Topics: Adult; Aged; Asymptomatic Diseases; Blood Glucose; Blood Sedimentation; C-Reactive Protein; Cardiovascular Diseases; Chronic Disease; Complement C3; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Humans; Inflammation; Male; Metabolome; Middle Aged; Prediabetic State; Risk Factors; Time Factors | 2014 |
Effective treatment with para-aminomethylbenzoic acid for chronic disseminated intravascular coagulation associated with aortic dissection.
Topics: Antifibrinolytic Agents; Aortic Diseases; Aortic Dissection; Aortography; Blood Vessel Prosthesis Implantation; Chronic Disease; Disseminated Intravascular Coagulation; Drugs, Chinese Herbal; Endovascular Procedures; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematuria; Humans; Male; Middle Aged; para-Aminobenzoates; Salvia miltiorrhiza; Stents; Tomography, X-Ray Computed | 2015 |
Fibrinogen plasma concentration is an independent marker of haemodynamic impairment in chronic thromboembolic pulmonary hypertension.
Topics: Aged; Biomarkers; Chronic Disease; Female; Fibrinogen; Follow-Up Studies; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; ROC Curve | 2014 |
Inflammatory markers as mortality predictors in continuous ambulatory peritoneal dialysis patients.
Topics: Aged; Biomarkers; Blood Sedimentation; C-Reactive Protein; Chronic Disease; Female; Fibrinogen; Humans; Inflammation; Kidney Failure, Chronic; Kidney Function Tests; Leukocyte Count; Male; Middle Aged; Peritoneal Dialysis; Predictive Value of Tests; Serbia; Survival Analysis | 2015 |
Association of socioeconomic status with inflammatory markers: a two cohort comparison.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Chronic Disease; Cohort Studies; Educational Status; Female; Fibrinogen; Health Behavior; Humans; Inflammation; Interleukin-6; Leukocytes; Logistic Models; Male; Middle Aged; Portugal; Risk Factors; Smoking; Social Class; Socioeconomic Factors; Surveys and Questionnaires; Switzerland; Tumor Necrosis Factor-alpha | 2015 |
Inflammation Partially Mediates the Association of Multimorbidity and Functional Limitations in a National Sample of Middle-Aged and Older Adults: The MIDUS Study.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; C-Reactive Protein; Chronic Disease; Comorbidity; Data Collection; Disabled Persons; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Middle Aged; United States | 2015 |
Bronchiectasis is a Model for Chronic Bacterial Infection Inducing Autoimmunity in Rheumatoid Arthritis.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Asthma; Autoantibodies; Autoimmunity; Bacterial Infections; Bronchiectasis; Case-Control Studies; Chronic Disease; Citrulline; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Male; Middle Aged; Peptides, Cyclic; Phosphopyruvate Hydratase; Rheumatoid Factor; Smoking; Vimentin | 2015 |
Chronic Migraineurs Form Carboxyhemefibrinogen and Iron-Bound Fibrinogen.
Topics: Anticoagulants; Blood Coagulation; Body Mass Index; Carbon Monoxide; Chronic Disease; Citrates; Female; Fibrinogen; Humans; Iron; Kinetics; Larva Migrans, Visceral; Male; Middle Aged; Sodium Citrate | 2015 |
Simple blood tests as predictive markers of disease severity and clinical condition in patients with venous insufficiency.
Topics: Adult; Biomarkers; Blood Platelets; Chronic Disease; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Leukocyte Count; Lymphocytes; Male; Mean Platelet Volume; Middle Aged; Neutrophils; Platelet Count; Prognosis; Prospective Studies; Sensitivity and Specificity; Serum Albumin; Severity of Illness Index; Venous Insufficiency | 2016 |
Effect of physical training on indices of platelet aggregation and fibrinogen concentration in patients with chronic heart failure.
Topics: Adenosine Diphosphate; Aged; Cardiac Rehabilitation; Chronic Disease; Dance Therapy; Epinephrine; Exercise Therapy; Female; Fibrinogen; Heart Failure; Humans; Male; Platelet Aggregation; Time Factors | 2015 |
Fibrinogen Reduction and Motor Function Improvement by Hematopoietic Growth Factor Treatment in Chronic Stroke in Aged Mice: A Treatment Frequency Study.
Topics: Aging; Animals; Chronic Disease; Disease Models, Animal; Fibrinogen; Granulocyte Colony-Stimulating Factor; Mice; Motor Activity; Stem Cell Factor; Stroke | 2016 |
High Fibrinogen Plus Low Plasminogen Levels Predict Poor Post-Surgical Survival in Patients With Chronic Thromboembolic Pulmonary Hypertension.
Topics: Chronic Disease; Coagulants; Fibrinogen; Humans; Hypertension, Pulmonary; Plasminogen; Pulmonary Embolism | 2016 |
Risk factors detection in chronic thromboembolic pulmonary hypertension, a tool for risk quantification?
Topics: Adult; Aged; Anticoagulants; Chronic Disease; Female; Fibrinogen; Humans; Hypertension, Pulmonary; Lung; Male; Middle Aged; Platelet Count; Prevalence; Pulmonary Embolism; Risk Factors; Venous Thrombosis | 2016 |
[Effect of atorvastatin treatment on the hemorheologic and hemostatic parameters in chronic cerebrovascular patients].
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Blood Viscosity; Cerebrovascular Disorders; Chronic Disease; Drug Administration Schedule; Endothelium, Vascular; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Hemorheology; Hemostasis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrroles; Stroke; von Willebrand Factor | 2008 |
High levels of high sensitivity C-reactive protein predict the progression of chronic rheumatic mitral stenosis.
Topics: Adult; Blood Platelets; Blood Pressure; C-Reactive Protein; Chronic Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Mitral Valve Stenosis; Rheumatic Diseases; Severity of Illness Index | 2009 |
Anaemia as an inflammation-mediated condition during chronic heart failure. Possible role of fibrinogen.
Topics: Aged; Anemia; Case-Control Studies; Chronic Disease; Female; Fibrinogen; Heart Failure; Humans; Inflammation; Italy; Logistic Models; Male; Retrospective Studies; Risk Factors; Stroke Volume; Ventricular Function, Left | 2008 |
Serum fibrinogen levels are an independent predictor of mortality in patients with chronic kidney disease (CKD) stages 3 and 4.
Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Chronic Disease; Cross-Sectional Studies; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Kidney Diseases; Longitudinal Studies; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Factors; Severity of Illness Index | 2008 |
Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.
Topics: Biomarkers; Chronic Disease; Cohort Studies; Creatinine; Disease Progression; Factor VIII; Female; Fibrinogen; Follow-Up Studies; Glomerular Filtration Rate; Hemostasis; Humans; Inflammation; Kidney Diseases; Leukocytes; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Serum Albumin; United States; von Willebrand Factor | 2009 |
Does inflammation fuel the fire in CKD?
Topics: Biomarkers; C-Reactive Protein; Chronic Disease; Disease Progression; Factor VII; Factor VIII; Fibrinogen; Glomerular Filtration Rate; Humans; Inflammation; Kidney Diseases; Leukocytes; Risk Factors; Serum Albumin; von Willebrand Factor | 2009 |
The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity.
Topics: Aged; Biomarkers; Bronchitis; C-Reactive Protein; Chronic Disease; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Metabolic Syndrome; Middle Aged; Motor Activity; Pulmonary Disease, Chronic Obstructive; Regression Analysis | 2009 |
The rheological profile of chronic liver disease patients in Nigeria.
Topics: Adult; Aged; Chronic Disease; Female; Fibrinogen; Hematocrit; Hemorheology; Hepatitis C; Humans; Liver Cirrhosis, Alcoholic; Liver Diseases; Male; Middle Aged; Nigeria; Platelet Count; Prospective Studies; Risk Factors; Young Adult | 2009 |
Successful use of spinal anesthesia in a patient with severe Klippel-Trénaunay syndrome associated with upper airway abnormalities and chronic Kasabach-Merritt coagulopathy.
Topics: Adult; Airway Obstruction; Anesthesia, Spinal; Arthroplasty, Replacement, Knee; Chronic Disease; Factor VIII; Female; Fibrinogen; Hemangioma, Cavernous; Humans; Klippel-Trenaunay-Weber Syndrome; Magnetic Resonance Imaging; Severity of Illness Index; Spine; Syndrome; Thrombocytopenia; Treatment Outcome; Young Adult | 2010 |
[Analysis of relative factors of restenosis after artificially grafting bypasses on chronic ischemia of lower extremities].
Topics: Aged; Blood Vessel Prosthesis Implantation; C-Reactive Protein; Chronic Disease; Diabetes Complications; Female; Fibrinogen; Graft Occlusion, Vascular; Humans; Interleukin-6; Ischemia; Lower Extremity; Male; Middle Aged; Prospective Studies; Risk Factors; Smoking; Transforming Growth Factor beta1 | 2009 |
Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Cohort Studies; Factor V; Factor VIII; Female; Fibrinogen; Humans; Hypertension, Pulmonary; Male; Middle Aged; Polymorphism, Genetic; Protein S; Pulmonary Embolism; Retrospective Studies; Risk Factors; Thrombosis; von Willebrand Factor; Young Adult | 2010 |
Lower-extremity functional electrical stimulation decreases platelet aggregation and blood coagulation in persons with chronic spinal cord injury: a pilot study.
Topics: Antithrombin III; Blood Coagulation; Blood Coagulation Factors; Chronic Disease; Cyclic AMP; Electric Stimulation Therapy; Ergometry; Exercise Therapy; Female; Fibrinogen; Humans; Lower Extremity; Male; Pilot Projects; Platelet Aggregation; Spinal Cord Injuries; Thrombin; Time Factors | 2010 |
Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chronic Disease; Cross-Sectional Studies; Dental Care; Female; Fibrinogen; Health Surveys; Humans; Infections; Male; Middle Aged; Patient Acceptance of Health Care; Periodontitis; Prevalence; Risk Factors; Scotland; Toothbrushing | 2010 |
Susceptibility to chronic thromboembolic pulmonary hypertension may be conferred by miR-759 via its targeted interaction with polymorphic fibrinogen alpha gene.
Topics: 3' Untranslated Regions; Adult; Aged; Blotting, Western; Chronic Disease; Female; Fibrinogen; Gene Expression; Genetic Predisposition to Disease; Humans; Hypertension, Pulmonary; Luciferases; Male; MicroRNAs; Middle Aged; Mutation; Polymorphism, Genetic; Pulmonary Embolism; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection | 2010 |
Fetuin-mineral complex reflects extraosseous calcification stress in CKD.
Topics: Aged; alpha-2-HS-Glycoprotein; Biomarkers; Blood Proteins; Calcinosis; Calcium; Case-Control Studies; Chronic Disease; Cinacalcet; Coronary Artery Disease; Female; Fibrinogen; Fibronectins; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Longitudinal Studies; Male; Middle Aged; Naphthalenes; Renal Dialysis; Severity of Illness Index | 2010 |
Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis.
Topics: 1-Naphthylisothiocyanate; Afibrinogenemia; Aged; Animals; Bile Ducts; Cholestasis; Chronic Disease; Collagen; Diet; Disease Models, Animal; Early Growth Response Protein 1; Feeding Behavior; Female; Fibrin; Fibrinogen; Gene Expression Regulation; Humans; Hyperplasia; Inflammation; Liver; Liver Cirrhosis; Male; Mice; Middle Aged; Neutrophils; Xenobiotics | 2011 |
Coagulation abnormalities in patients with chronic liver disease in Pakistan.
Topics: Adolescent; Adult; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelet Disorders; Chronic Disease; Confidence Intervals; Female; Fibrinogen; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Hospitals, University; Humans; Liver Diseases; Male; Middle Aged; Pakistan; Partial Thromboplastin Time; Prothrombin Time; Risk; Risk Factors; Sex Distribution; Thrombocytopenia; Young Adult | 2011 |
[Endothelium-protective effects of vinpocetine, pentoxifylline and enalapril in patients with chronic brain ischemia].
Topics: Adult; Aged; Antihypertensive Agents; Brain Ischemia; Case-Control Studies; Cerebrovascular Circulation; Cholesterol; Chronic Disease; Dose-Response Relationship, Drug; Enalapril; Endothelium, Vascular; Fibrinogen; Humans; Middle Aged; Pentoxifylline; Treatment Outcome; Vasodilation; Vasodilator Agents; Vinca Alkaloids; von Willebrand Factor | 2011 |
Immunohistochemical differences between normal and chronically inflamed conjunctiva: diagnostic features.
Topics: Basement Membrane; Biomarkers; Biopsy; Case-Control Studies; Chronic Disease; Conjunctiva; Conjunctivitis; Cross-Sectional Studies; Diagnosis, Differential; Fibrinogen; Fluorescent Antibody Technique; Humans; Lichen Planus; Massachusetts; Pemphigoid, Benign Mucous Membrane; Predictive Value of Tests; Prognosis; Prospective Studies | 2011 |
Hypercoagulation in chronic post-traumatic stress disorder.
Topics: Activated Protein C Resistance; Adult; Biomarkers; Blood Coagulation Factors; Chronic Disease; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Israel; Male; Peptide Fragments; Protein Precursors; Prothrombin; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Thrombophilia; Thromboplastin; von Willebrand Factor | 2011 |
Clinical significance of haemostatic tests in chronic liver disease.
Topics: Adult; Antithrombin III; Biomarkers; Blood Coagulation Tests; Chronic Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; International Normalized Ratio; Liver Cirrhosis; Male; Middle Aged; Partial Thromboplastin Time; Protein C | 2012 |
Therapeutic potential of ASP3258, a selective phosphodiesterase 4 inhibitor, on chronic eosinophilic airway inflammation.
Topics: Animals; Asthma; Bronchial Hyperreactivity; Chronic Disease; Eosinophilia; Female; Fibrinogen; Humans; Interleukin-5; Male; Naphthyridines; Phosphodiesterase 4 Inhibitors; Rats; Rats, Inbred BN; Rats, Inbred F344; Tumor Necrosis Factor-alpha | 2012 |
Sleep and biomarkers in the English Longitudinal Study of Ageing: associations with C-reactive protein, fibrinogen, dehydroepiandrosterone sulfate and hemoglobin.
Topics: Aged; Aged, 80 and over; Aging; Anemia; Biomarkers; Body Mass Index; C-Reactive Protein; Chronic Disease; Comorbidity; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Depression; England; Female; Fibrinogen; Follow-Up Studies; Hemoglobins; Humans; Male; Middle Aged; Motor Activity; Prospective Studies; Self Report; Sex Factors; Sleep; Sleep Wake Disorders; Smoking; Socioeconomic Factors | 2013 |
Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: a nested case-control study from the Bezafibrate Infarction Prevention (BIP) study cohort.
Topics: Bezafibrate; Biomarkers; Brain Ischemia; Case-Control Studies; Chronic Disease; Cohort Studies; Comorbidity; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Hypolipidemic Agents; Intercellular Adhesion Molecule-1; Israel; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Stroke | 2002 |
Balloon angioplasty in chronic critical limb ischemia: factors affecting clinical and angiographic outcome.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Chronic Disease; Female; Fibrinogen; Hemodynamics; Humans; Ischemia; Leg; Male; Middle Aged; Prognosis; Prospective Studies; Recurrence | 2002 |
Influence of chronic Helicobacter pylori infection on ischemic cerebral stroke risk factors.
Topics: Aged; Antigens, Bacterial; Bacterial Proteins; Brain Ischemia; Breath Tests; Cholesterol; Cholesterol, LDL; Chronic Disease; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Interleukin-8; Middle Aged; Risk Factors; RNA, Ribosomal, 16S; Stroke | 2002 |
[Chronic Chlamydia pneumoniae infection in patients with coronary disease. Relation with increased fibrinogen values].
Topics: Antibodies, Bacterial; C-Reactive Protein; Chlamydia Infections; Chlamydophila pneumoniae; Chronic Disease; Coronary Artery Disease; Female; Fibrinogen; Humans; Immunoglobulin M; Male; Middle Aged | 2002 |
Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Echocardiography; Endothelial Growth Factors; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Follow-Up Studies; Heart Failure; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Middle Aged; P-Selectin; Risk Factors; Severity of Illness Index; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Ventricular Function, Left | 2002 |
Increase of arterial thrombosis parameters in chronic Helicobacter pylori infection in mice.
Topics: Animals; Bacterial Proteins; Chronic Disease; Disease Models, Animal; Embolism; Erythrocyte Count; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Lasers; Leukocyte Count; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Platelet Aggregation; Platelet Count; Polymerase Chain Reaction; Thrombosis | 2002 |
Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors.
Topics: Adiponectin; Adult; Aged; Blood Pressure; Chronic Disease; Female; Fibrinogen; Humans; Hyperlipidemias; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Nephrotic Syndrome; Proteins; Proteinuria; Risk Factors; Serum Albumin | 2003 |
Association of increased levels of fibrinogen and the -455G/A fibrinogen gene polymorphism with chronic periodontitis.
Topics: 5' Flanking Region; Adenine; Age Factors; Aged; Alleles; Analysis of Variance; Case-Control Studies; Chronic Disease; Confidence Intervals; Female; Fibrinogen; Genotype; Guanine; Homozygote; Humans; Male; Middle Aged; Odds Ratio; Periodontitis; Polymorphism, Genetic; Promoter Regions, Genetic; Sex Factors; Smoking | 2003 |
C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Chronic Disease; Cross-Sectional Studies; Cytokines; Female; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Japan; Kidney Failure, Chronic; Lipoprotein(a); Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis; Risk Factors; Sex Factors; Ultrasonography | 2003 |
Serum alpha1-antitrypsin but not complement C3 and C4 predicts chronic inflammation in hemodialysis patients.
Topics: Adolescent; Adult; Aged; alpha 1-Antitrypsin; Biomarkers; C-Reactive Protein; Chronic Disease; Complement C3; Complement C4; Female; Fibrinogen; Humans; Inflammation; Lipoprotein(a); Male; Middle Aged; Orosomucoid; Predictive Value of Tests; Renal Dialysis; Serum Albumin; Statistics as Topic; Treatment Outcome; von Willebrand Factor | 2003 |
[Oxidase activity of ceruloplasmin and the state of hemocoagulation in patients with chronic pancreatitis].
Topics: Adult; Aged; Blood Coagulation; Ceruloplasmin; Chronic Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Oxidoreductases; Pancreatitis; Time Factors | 2003 |
The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins B; C-Reactive Protein; Chronic Disease; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Diseases; Lipoprotein(a); Male; Middle Aged; Risk Factors | 2004 |
Summaries for patients. Associations of newer cardiac risk factors with chronic kidney disease.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins B; C-Reactive Protein; Chronic Disease; Coronary Disease; Female; Fibrinogen; Homocysteine; Humans; Kidney Diseases; Lipoprotein(a); Male; Middle Aged; Risk Factors | 2004 |
Evolution of plasma D-dimer and fibrinogen in witnessed onset of paroxysmal atrial fibrillation.
Topics: Acute Disease; Aged; Aged, 80 and over; Atrial Fibrillation; Chronic Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Predictive Value of Tests; Time Factors | 2004 |
Activation of coagulation occurs after electrical cardioversion in patients with chronic atrial fibrillation despite optimal anticoagulation with warfarin.
Topics: Adult; Aged; Anticoagulants; Antithrombin III; Atrial Fibrillation; Biomarkers; Blood Coagulation; Chronic Disease; Electric Countershock; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Protein C; Treatment Outcome; United Kingdom; Warfarin | 2004 |
Asymptomatic cerebral lacunae in patients with chronic kidney disease.
Topics: Anemia; Brain Infarction; Carotid Artery Diseases; Chronic Disease; Comorbidity; Creatinine; Electrocardiography; Female; Fibrinogen; Hematocrit; Homocysteine; Humans; Hypertension; Insulin; Insulin Resistance; Kidney Diseases; Kidney Function Tests; Lipoprotein(a); Magnetic Resonance Imaging; Male; Middle Aged; Obesity; Prevalence; Regression Analysis; Risk Factors; Ultrasonography | 2004 |
Hemorheological disturbances in patients with chronic cerebrovascular diseases.
Topics: Adult; Alcohol Drinking; Blood Viscosity; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Diabetes Mellitus; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Hyperlipidemias; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Ischemia; Reference Values; Risk Factors; Smoking | 2004 |
Association between leisure time physical activity and markers of chronic inflammation related to coronary heart disease.
Topics: Adult; Biomarkers; C-Reactive Protein; Chronic Disease; Coronary Artery Disease; Cross-Sectional Studies; Exercise; Fibrinogen; Humans; Inflammation; Life Style; Male; Middle Aged; Recreation; Risk Factors; Serum Amyloid A Protein | 2004 |
Optimistic for longevity.
Topics: Aged; Attitude; Biomarkers; Chronic Disease; Depression; Diabetes Mellitus; Fibrinogen; Happiness; Health Status; Heart Diseases; Humans; Hydrocortisone; Inflammation; Longevity; Middle Aged | 2005 |
[Diagnostics and therapeutic approach in clinical remission of chronic bronchitis].
Topics: Adult; Biomarkers; Bronchitis; Catalase; Ceruloplasmin; Chronic Disease; Disease-Free Survival; Erythrocytes; Female; Fibrinogen; Haptoglobins; Humans; Immunoglobulins; Lipid Peroxidation; Male; Malondialdehyde; Neutrophils; Peroxidase; Phagocytosis; Physical Therapy Modalities; Sialic Acids; Superoxide Dismutase; T-Lymphocytes | 2005 |
Prediction model of coronary heart disease in patients with chronic kidney disease: role of plasma fibrinogen as a new prognostic variable.
Topics: Aged; Biomarkers; Chronic Disease; Coronary Disease; Female; Fibrinogen; Humans; Kidney Diseases; Male; Middle Aged; Models, Statistical; Prognosis; Risk Factors; Sensitivity and Specificity | 2005 |
Elevated plasma cryofibrinogen in patients with active inflammatory bowel disease is morbigenous.
Topics: Adolescent; Adult; Antibodies; Biomarkers; Blood Sedimentation; C-Reactive Protein; Chronic Disease; Cryoglobulins; Female; Fibrinogen; Fibrinogens, Abnormal; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Trypsin Inhibitors | 2006 |
[The predictive value of serum advanced fibrinogen and uric acid for acute coronary event risk].
Topics: Aged; Blood Glucose; Chronic Disease; Coronary Disease; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Uric Acid | 2006 |
[Effect of cavinton on the hemorheological parameters of chronic cerebrovascular patients].
Topics: Blood Viscosity; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Erythrocyte Aggregation; Female; Fibrinogen; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Neuroprotective Agents; Treatment Outcome; Vinca Alkaloids | 2006 |
Incidence and risk factors for the development of prolonged and severe intrahepatic cholestasis after liver transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Aging; Bacteremia; Blood Group Incompatibility; Child; Cholestasis, Intrahepatic; Chronic Disease; Factor VIII; Female; Fibrinogen; Humans; Incidence; Intraoperative Care; Liver Failure; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Platelet Transfusion; Potassium; Risk Factors; Severity of Illness Index; Sodium; Time Factors | 2006 |
Chronic cicatrizing conjunctivitis in a patient with epidermolysis bullosa acquisita.
Topics: Adult; Autoantibodies; Autoantigens; Chronic Disease; Cicatrix; Complement C3; Conjunctivitis; Epidermolysis Bullosa Acquisita; Fibrinogen; Fluorescent Antibody Technique, Direct; Humans; Immunoglobulin G; Immunoglobulin Isotypes; Immunoglobulins, Intravenous; Male | 2006 |
Fibrinogen metabolism in patients with spinal cord injury.
Topics: Acute Disease; Adult; Case-Control Studies; Chronic Disease; Disease Progression; Fibrin; Fibrinogen; Half-Life; Humans; Iodine Radioisotopes; Male; Middle Aged; Paralysis; Pulmonary Embolism; Risk Factors; Spinal Cord Injuries; Time Factors; Venous Thrombosis | 2006 |
Lack of synergistic effects of metabolic syndrome and plasma fibrinogen on coronary events and mortality in moderate CKD.
Topics: Chronic Disease; Cohort Studies; Coronary Artery Disease; Female; Fibrinogen; Humans; Inflammation; Kidney Diseases; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Regression Analysis | 2007 |
Comparison of rheological parameters in patients with post hepatitic and alcoholic cirrhosis.
Topics: Blood Viscosity; Chronic Disease; Erythrocyte Count; Erythrocyte Deformability; Fibrinogen; gamma-Globulins; Hemorheology; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Reference Values | 2007 |
Mechanism of saikosaponin-d in the regulation of rat mesangial cell proliferation and synthesis of extracellular matrix proteins.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Proliferation; Cells, Cultured; Chronic Disease; Collagen Type IV; Cyclin-Dependent Kinase 4; Down-Regulation; Female; Fibrinogen; Glomerulosclerosis, Focal Segmental; JNK Mitogen-Activated Protein Kinases; Male; Mesangial Cells; Oleanolic Acid; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Rats, Wistar; Saponins; Signal Transduction | 2007 |
In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers.
Topics: Acute Disease; Aged; Angina Pectoris; Biomarkers; C-Reactive Protein; Chronic Disease; Female; Fibrinogen; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Male; Matrix Metalloproteinase 9; Middle Aged; Myocardial Ischemia; Odds Ratio; Predictive Value of Tests; Prospective Studies; Receptors, Interleukin-1; Reproducibility of Results; Research Design; ROC Curve; Sensitivity and Specificity; Syndrome; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Treatment Outcome; Ventricular Remodeling | 2007 |
Interferon-gamma exacerbates liver damage, the hepatic progenitor cell response and fibrosis in a mouse model of chronic liver injury.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chronic Disease; Diet; Disease Models, Animal; Fibrinogen; Hepatocytes; Inflammation; Interferon-gamma; Liver Cirrhosis; Mice; Recombinant Proteins; Stem Cells | 2007 |
Fibrinogen synthesis is increased in cachectic patients with chronic heart failure.
Topics: Aged; Cachexia; Chronic Disease; Fibrinogen; Heart Failure; Humans; Male | 2008 |
Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test.
Topics: Acute Disease; Adult; Aged; Angina Pectoris; Blood Coagulation; Blood Coagulation Tests; C-Reactive Protein; Case-Control Studies; Chronic Disease; Coronary Artery Disease; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Thrombin; Time Factors; Up-Regulation | 2008 |
Inflammation and cardiovascular events in individuals with and without chronic kidney disease.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chronic Disease; Female; Fibrinogen; Humans; Inflammation; Kidney Diseases; Leukocyte Count; Male; Middle Aged; Risk Factors; Serum Albumin | 2008 |
Cumulative life course and adult socioeconomic status and markers of inflammation in adulthood.
Topics: Adult; Atherosclerosis; Biomarkers; Black or African American; C-Reactive Protein; Child; Chronic Disease; Educational Status; Employment; Fibrinogen; Humans; Inflammation; Leukocyte Count; Linear Models; North Carolina; Quality of Life; Residence Characteristics; Retrospective Studies; Social Class; von Willebrand Factor; White People | 2008 |
Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant.
Topics: Child; Chronic Disease; Coumarins; Disseminated Intravascular Coagulation; Fibrinogen; Gangrene; Glycoproteins; Humans; Infant, Newborn; Male; Metabolism, Inborn Errors; Pedigree; Protein C; Purpura; Skin; Syndrome | 1983 |
A fibrinolytic defect in chronic back pain syndromes.
Topics: Adult; alpha-2-Antiplasmin; Back Pain; Chronic Disease; Female; Fibrinogen; Fibrinolysis; Humans; Macroglobulins; Male; Middle Aged; Plasminogen; Syndrome | 1984 |
Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy.
Topics: Adolescent; Adult; Chronic Disease; Complement C3; Female; Fibrinogen; Fluorescent Antibody Technique; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin Light Chains; Immunoglobulin M; Male; Middle Aged; Peripheral Nervous System Diseases; Polyneuropathies; Schwann Cells; Sural Nerve | 1980 |
Comprehensive study of haemostasis in chronic uraemia.
Topics: Adult; Blood Coagulation Factors; Chronic Disease; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostasis; Humans; Plasminogen; Platelet Adhesiveness; Platelet Factor 3; Uremia; Urokinase-Type Plasminogen Activator | 1983 |
[Blood coagulability in chronic respiratory failure].
Topics: Adult; Aged; Blood Coagulation Factors; Chronic Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Respiratory Insufficiency | 1984 |
[Behavior of the fibrinogen polymerization curve in patients with chronic respiratory insufficiency].
Topics: Adult; Antithrombin III; Chronic Disease; Female; Fibrin; Fibrinogen; Humans; Male; Middle Aged; Respiratory Insufficiency | 1983 |
[Various indices of blood lipid composition in patients with chronic ischemic heart disease].
Topics: Cholesterol; Chronic Disease; Coronary Disease; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Triglycerides | 1983 |
[Lipid-metabolic and blood coagulation factors in chronic peripheral arteriopathies].
Topics: Adult; Aged; Antithrombin III; Arterial Occlusive Diseases; Chronic Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Thrombocytosis | 1983 |
Evidence of impaired anterior segment fibrinolytic activity in chronic uveitis.
Topics: Animals; BCG Vaccine; Cats; Chronic Disease; Endotoxins; Escherichia coli; Eye; Fibrinogen; Fibrinolysis; In Vitro Techniques; Injections; Uveitis | 1982 |
[Differential diagnostic importance of the immunochemical determination of blood serum, bile and urinary proteins in chronic liver and biliary tract diseases].
Topics: Albumins; Bile; Biliary Tract Diseases; Blood Proteins; Chronic Disease; Diagnosis, Differential; Fibrinogen; Humans; Immunodiffusion; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Liver Diseases; Proteinuria | 1980 |
Factors affecting coagulation: fibrinolysis in chronic subdural fluid collections.
Topics: alpha-2-Antiplasmin; Chronic Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hematoma, Subdural; Hemoglobins; Humans; Plasminogen | 1983 |
[Fibrinogen-bound sterols in diabetes mellitus patients].
Topics: Adult; Aged; Chronic Disease; Diabetes Mellitus; Fibrinogen; Humans; Middle Aged; Protein Binding; Sterols | 1983 |
Vascular immunopathology in interstitial cystitis.
Topics: Blood Vessels; Chronic Disease; Complement Activating Enzymes; Complement C1q; Complement C3; Cystitis; Female; Fibrinogen; Humans; Immunoglobulin M; Male; Mast Cells; Middle Aged; Mucous Membrane; Skin; Urinary Bladder | 1982 |
Chronic relapsing experimental allergic encephalomyelitis. Immunohistochemical studies.
Topics: Animals; Brain; Choroid Plexus; Chronic Disease; Encephalomyelitis, Autoimmune, Experimental; Fibrinogen; Fluorescent Antibody Technique; Guinea Pigs; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Periodicity; Remission, Spontaneous; Spinal Cord | 1980 |
[Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].
Topics: Adult; Aged; Ancrod; Arterial Occlusive Diseases; Blood Coagulation; Blood Viscosity; Chronic Disease; Drug Evaluation; Female; Fibrinogen; Humans; Male; Middle Aged | 1982 |
[comparison of indices of the blood rheological status in chronic ischemic heart disease].
Topics: Blood Viscosity; Chronic Disease; Coronary Disease; Erythrocyte Aggregation; Female; Fibrin; Fibrinogen; Humans; In Vitro Techniques; Male; Rheology | 1982 |
Chronic intravascular coagulation in normal pregnancy and preeclampsia.
Topics: Blood Coagulation Factors; Blood Platelets; Chronic Disease; Disseminated Intravascular Coagulation; Female; Fibrinogen; Humans; Kidney; Microscopy, Electron; Platelet Aggregation; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Prothrombin | 1981 |
Intraperitoneal coagulation in chronic liver disease ascites.
Topics: Ascites; Ascitic Fluid; Blood Coagulation; Blood Proteins; Chronic Disease; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Diseases; Peritoneal Cavity | 1981 |
Clinical significance of "circulating fibrin monomers'.
Topics: Chronic Disease; Ethanol; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhagic Disorders; Humans; Male; Neoplasms; Thromboembolism; Time Factors | 1981 |
Practical impact of hemorheology on the treatment of chronic peripheral ischemia.
Topics: Ancrod; Aspirin; Blood Viscosity; Chronic Disease; Erythrocyte Count; Fibrinogen; Humans; Intermittent Claudication; Ischemia; Lipid Metabolism; Myocardial Infarction; Plasma Exchange; Rheology; Vascular Diseases; Vasodilator Agents | 1981 |
[Changes in some blood chemical parameters in patients with chronic liver diseases treated with calcium-2,2'-disulfohexanoate].
Topics: Alkaline Phosphatase; Ammonia; Bilirubin; Caproates; Chronic Disease; Copper; Disulfides; Female; Fibrinogen; Humans; Hyperbilirubinemia; Iron; L-Lactate Dehydrogenase; Liver Diseases; Male; Transaminases | 1980 |
Venous thromboembolism in decompensated chronic obstructive pulmonary disease. A prospective study.
Topics: Aged; Chronic Disease; Female; Fibrinogen; Humans; Leg; Lung Diseases, Obstructive; Male; Middle Aged; Phlebography; Plethysmography, Impedance; Prospective Studies; Pulmonary Embolism; Thrombophlebitis; Ultrasonography | 1981 |
[Study of behaviour of fibrinogen and of some glycoproteins in arteriosclerotic clinical situations (author's transl)].
Topics: Acute Disease; Arteriosclerosis; Chronic Disease; Coronary Disease; Diabetic Angiopathies; Fibrinogen; Glycoproteins; Humans; Hyperlipoproteinemias; Myocardial Infarction | 1980 |
Catabolism of human fibrinogen fragment D in normal subjects and patients with liver cirrhosis.
Topics: Adult; Aged; Chronic Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Half-Life; Humans; Iodine Radioisotopes; Isotope Labeling; Liver; Liver Cirrhosis, Alcoholic; Metabolic Clearance Rate; Middle Aged | 1980 |
Sustained activation of blood coagulation in patients with cerebral thrombosis.
Topics: Acute Disease; Adult; Aged; alpha-2-Antiplasmin; Antithrombin III; Blood Coagulation; Blood Coagulation Factors; Chronic Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Hemostasis; Humans; Intracranial Embolism and Thrombosis; Male; Middle Aged; Thrombin; von Willebrand Factor | 1995 |
Autoantibodies to cryptic epitopes of C-reactive protein and other acute phase proteins in the toxic oil syndrome.
Topics: Acute-Phase Proteins; alpha 1-Antitrypsin; Aniline Compounds; Autoantibodies; Autoantigens; Autoimmune Diseases; Brassica; C-Reactive Protein; Ceruloplasmin; Chronic Disease; Cross Reactions; Epitopes; Fatty Acids, Monounsaturated; Fibrinogen; Plant Oils; Poisoning; Protein Denaturation; Rapeseed Oil; Spain | 1995 |
Increasing erythrocyte aggregability with the progressive grades of chronic venous insufficiency: importance and mechanisms.
Topics: Adult; Aged; Analysis of Variance; Chronic Disease; Data Interpretation, Statistical; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Varicose Veins; Venous Insufficiency | 1995 |
[Fibrinolysis in chronic liver diseases studied by in vitro blood coagulation tests].
Topics: Adult; Aged; Antifibrinolytic Agents; Blood Coagulation Tests; Cholestasis; Chronic Disease; Female; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Male; Middle Aged; Prognosis; Tissue Plasminogen Activator | 1994 |
Fibrinogen: a link between chronic infection and coronary heart disease.
Topics: Aged; Chlamydia Infections; Chlamydophila pneumoniae; Chronic Disease; Coronary Disease; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Risk Factors | 1994 |
Characterization of local hyperfibrinolysis in chronic subdural hematomas by SDS-PAGE and immunoblot.
Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation Disorders; Chronic Disease; Electrophoresis, Polyacrylamide Gel; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hematoma, Subdural; Humans; Immunoblotting; Male; Middle Aged; Recurrence; Sodium Dodecyl Sulfate | 1994 |
Impact of risk factors on limb salvage after angioplasty in chronic critical lower limb ischemia. A prospective trial.
Topics: Adult; Aged; Angioplasty, Balloon; Cholesterol, HDL; Chronic Disease; Female; Fibrinogen; Humans; Ischemia; Leg; Male; Middle Aged; Prospective Studies; Risk Factors; Treatment Outcome | 1994 |
[Plasma fibrinogen and cardiovascular risk factors. The experience of the Integrated Community Control Project on Chronic Degenerative Diseases in the Health District of Sezze--Di.S.Co. The Research Group].
Topics: Adult; Age Distribution; Aged; Arteriosclerosis; Cardiovascular Diseases; Chronic Disease; Female; Fibrinogen; Humans; Italy; Linear Models; Male; Middle Aged; Risk Factors; Sex Distribution | 1994 |
Essential cryofibrinogenaemia, leukocytoclastic vasculitis and chronic purpura.
Topics: Adult; Chronic Disease; Cryoglobulinemia; Cryoglobulins; Female; Fibrinogen; Fibrinogens, Abnormal; Humans; Purpura; Vasculitis, Leukocytoclastic, Cutaneous | 1993 |
Pre- and intraoperative differences between patients with chronic liver disease and fulminant hepatic failure undergoing liver transplant.
Topics: Blood Component Transfusion; Blood Glucose; Cardiac Output; Chronic Disease; Creatinine; Electrolytes; Fibrinogen; Hematocrit; Hemodynamics; Hemoglobins; Hepatic Encephalopathy; Humans; Liver Failure; Monitoring, Intraoperative; Platelet Count; Prothrombin Time; Vascular Resistance | 1993 |
Haemostatic and immunological sequelae of portacaval shunt in rats.
Topics: Animals; Cell Division; Chronic Disease; Cytokines; Fibrinogen; Hemostasis; Kupffer Cells; Liver Diseases; Lymphocytes; Male; Portacaval Shunt, Surgical; Postoperative Complications; Rats | 1995 |
Hemostatic abnormalities may predict chronic hypertension after preeclampsia.
Topics: Adult; Antithrombin III; Blood Coagulation Disorders; Blood Coagulation Factors; Chronic Disease; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hypertension; Peptide Fragments; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Pre-Eclampsia; Pregnancy; Prothrombin; Risk Factors; Thrombin | 1996 |
[Effect of treating glomerulonephritis with omega 3 fatty acids for selected parameters of hemostasis, blood platelet function and lipid metabolism].
Topics: Adult; Blood Platelets; Chronic Disease; Fatty Acids, Omega-3; Fibrinogen; Fish Oils; Glomerulonephritis; Hemostasis; Humans; Lipids; Platelet Function Tests; Triglycerides | 1996 |
Increased lipoproteins and fibrinogen in chronic renal allograft dysfunction.
Topics: Adult; Apolipoproteins B; Cholesterol, HDL; Chronic Disease; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Graft Rejection; Humans; Kidney Transplantation; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Transplantation, Homologous; Triglycerides | 1997 |
[Chronic metabolic syndrome: a predictive model of risk of macrovascular events?].
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Cholesterol, HDL; Chronic Disease; Female; Fibrinogen; Humans; Logistic Models; Male; Microvascular Angina; Middle Aged; Prognosis; Random Allocation; Risk Factors | 1997 |
Stress response to chronic inflammation in the horse.
Topics: Animals; Blood Glucose; Body Temperature; Chronic Disease; Fibrinogen; Freund's Adjuvant; Horse Diseases; Horses; Hydrocortisone; Inflammation; Injections, Intramuscular; Insulin; Male; Models, Biological; Soft Tissue Injuries; Stress, Physiological | 1997 |
Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease.
Topics: Angina, Unstable; Antibodies, Anti-Idiotypic; Anticoagulants; Biomarkers; C-Reactive Protein; Chlamydia Infections; Chronic Disease; Dalteparin; Female; Fibrinogen; Humans; Immunoglobulin A; Immunoglobulin G; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Pneumonia, Bacterial; Prevalence; Prognosis; Risk Factors | 1998 |
Neurobiology of the association of chronic work stress with atherogenic lipids and elevated fibrinogen in middle-aged men.
Topics: Chronic Disease; Employment; Fibrinogen; Humans; Lipids; Male; Middle Aged; Stress, Psychological | 1998 |
Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances.
Topics: Acute Disease; Adsorption; Bilirubin; Biocompatible Materials; Chronic Disease; Dialysis; Equipment Design; Equipment Safety; Fibrinogen; Filtration; Hemodiafiltration; Humans; Immunoglobulin G; Immunoglobulin M; Liver Diseases; Membranes, Artificial; Molecular Weight; Polymers; Protein Binding; Serum Albumin; Sulfones; Tryptophan | 1999 |
Symptoms of chronic bronchitis, haemostatic factors, and coronary heart disease risk.
Topics: Blood Coagulation Factors; Body Mass Index; Bronchitis; Chronic Disease; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Finland; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Plasminogen; Retrospective Studies; Risk Factors; Smoking; Surveys and Questionnaires | 1999 |
[Local activation of blood coagulation in pancreatic tissue in chronic pancreatitis].
Topics: Antibodies, Monoclonal; Blood Coagulation; Chronic Disease; Fibrinogen; Humans; Immunohistochemistry; Pancreatitis; Thromboplastin; Whole Blood Coagulation Time | 1998 |
Recurrent and persistent coagulopathy following pit viper envenomation.
Topics: Adolescent; Adult; Aged; Animals; Antivenins; Blood Coagulation Disorders; Child; Chronic Disease; Crotalid Venoms; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Middle Aged; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; Recurrence; Snake Bites; Time Factors; Viper Venoms; Viperidae | 1999 |
Histological evidence of concomitant intramyocardial and epicardial vasculitis in necropsied heart allografts: a possible relationship with graft coronary arteriosclerosis.
Topics: Acute Disease; Antibodies, Viral; Chronic Disease; Complement System Proteins; Coronary Artery Disease; Coronary Vessels; Cytomegalovirus; Female; Fibrinogen; Fluorescent Antibody Technique; Frozen Sections; Graft Rejection; Heart Transplantation; Humans; Immunoenzyme Techniques; Immunoglobulins; Male; Myocardial Ischemia; Myocardium; Postmortem Changes; Vasculitis | 1999 |
Increased plasma levels of fibrinogen in acute and chronic ischemic coronary syndromes.
Topics: Acute Disease; Aged; Analysis of Variance; Angina, Unstable; Chronic Disease; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Risk Factors; Syndrome; Time Factors | 1999 |
Hemorheological profile in chronic venous insufficiency after surgery.
Topics: Adult; Aged; Analysis of Variance; Chronic Disease; Erythrocyte Aggregation; Female; Fibrinogen; Follow-Up Studies; Hematocrit; Hemorheology; Humans; Male; Middle Aged; Saphenous Vein; Time Factors; Venous Insufficiency | 1999 |
[Changes in fibrinogen, fibrin-fibrinogen degradation products and fibrinolytic activity during pregnancy, labor and the puerperium in pregnant women with chronic hypertension].
Topics: Adult; Chronic Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Hypertension; Labor, Obstetric; Postpartum Period; Pre-Eclampsia; Pregnancy | 2000 |
Plasma viscosity and fibrinogen in relation to haemodynamic findings in chronic congestive heart failure.
Topics: Adult; Aged; Biomarkers; Blood Viscosity; Chronic Disease; Disease Progression; Female; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Prognosis; Radionuclide Ventriculography; Stroke Volume | 1999 |
Increased platelet activation and endothelial dysfunction in patients with atrial fibrillation immediately following percutaneous balloon mitral valvuloplasty.
Topics: Atrial Fibrillation; Catheterization; Chronic Disease; Endothelium, Vascular; Female; Fibrinogen; Humans; Male; Middle Aged; Mitral Valve Stenosis; P-Selectin; Platelet Activation; von Willebrand Factor | 2000 |
Increased glomerular deposits of von Willebrand factor in chronic, but not acute, rejection of primate renal allografts.
Topics: Acute Disease; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Chronic Disease; Coloring Agents; Fibrinogen; Graft Rejection; Immune Tolerance; Immunotoxins; Kidney Glomerulus; Kidney Transplantation; Macaca mulatta; Macrophages; Male; von Willebrand Factor | 2000 |
Effect of degree of blood pressure on the hypercoagulable state in chronic atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Blood Coagulation; Blood Pressure; Chronic Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; von Willebrand Factor | 2000 |
Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Biomarkers; Chronic Disease; Endothelium, Vascular; Female; Fibrinogen; Heart Atria; Hemodynamics; Humans; Male; Middle Aged; Plasminogen Inactivators; Platelet Activation; von Willebrand Factor | 2000 |
Airway inflammation and etiology of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Aged; Aged, 80 and over; Bronchitis; Chronic Disease; Fibrinogen; Haemophilus; Haemophilus influenzae; Humans; Inflammation; Inflammation Mediators; Interleukin-8; Leukocyte Elastase; Longitudinal Studies; Male; Middle Aged; Moraxella catarrhalis; Prospective Studies; Sputum; Tumor Necrosis Factor-alpha | 2000 |
Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model.
Topics: Animals; Blood-Brain Barrier; Brain; Chronic Disease; Disease Models, Animal; Disease Progression; Endothelium, Vascular; Fibrinogen; Glucose Transporter Type 1; Host-Parasite Interactions; Intercellular Adhesion Molecule-1; Male; Membrane Proteins; Microcirculation; Monosaccharide Transport Proteins; Occludin; Phosphoproteins; Rats; Tight Junctions; Trypanosoma brucei brucei; Trypanosomiasis, African; Vascular Cell Adhesion Molecule-1; Zonula Occludens-1 Protein | 2001 |
Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation.
Topics: Adult; Aged; Atrial Fibrillation; Chronic Disease; Exercise; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; P-Selectin; von Willebrand Factor | 2001 |
Prothrombotic markers in atrial fibrillation: what is new?
Topics: Atrial Fibrillation; Biomarkers; Chronic Disease; Fibrinogen; Humans; P-Selectin; Stroke; von Willebrand Factor | 2001 |
Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
Topics: Adult; Aged; Atrial Fibrillation; Atrial Function, Left; Biomarkers; Chronic Disease; Cross-Sectional Studies; Echocardiography, Doppler; Electric Countershock; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; P-Selectin; Predictive Value of Tests; Regression Analysis; von Willebrand Factor | 2001 |
Platelet-associated anti-GPIIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura recognizing epitopes close to the ligand-binding site of glycoprotein (GP) IIb.
Topics: Adult; Aged; Antibodies, Monoclonal; Autoantibodies; Autoantigens; Binding Sites; Blood Platelets; Cell Line; Chronic Disease; Enzyme-Linked Immunosorbent Assay; Epitopes; Female; Fibrinogen; Humans; Male; Middle Aged; Mutation; Platelet Glycoprotein GPIIb-IIIa Complex; Purpura, Thrombocytopenic, Idiopathic | 2001 |
Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Body Mass Index; Bronchitis; Chronic Disease; Data Interpretation, Statistical; Denmark; Female; Fibrinogen; Forced Expiratory Volume; Hospitalization; Humans; Linear Models; Lung; Male; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Risk; Risk Factors; Smoking | 2001 |
The relation of body fat mass and distribution to markers of chronic inflammation.
Topics: Adipose Tissue; Adult; Aged; Arteriosclerosis; Biomarkers; Body Composition; Body Constitution; Body Mass Index; C-Reactive Protein; Carotid Arteries; Chronic Disease; Cross-Sectional Studies; Female; Fibrinogen; Glucose Tolerance Test; Humans; Inflammation; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Sex Factors | 2001 |
[The status of coagulation and lipid blood spectrum in patients with peptic ulcer complicated by ischemic heart disease].
Topics: Adult; Aged; Blood Coagulation Disorders; Cholesterol, HDL; Chronic Disease; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hyperlipidemias; Middle Aged; Myocardial Ischemia; Peptic Ulcer; Triglycerides | 2001 |
Genetic links between the acute-phase response and arthritis development in rats.
Topics: Acute Disease; Acute-Phase Proteins; Animals; Arthritis, Rheumatoid; Breeding; Chronic Disease; Disease Models, Animal; Female; Fibrinogen; Genotype; Immunosuppressive Agents; Interleukin-6; Joints; Lod Score; Male; Orosomucoid; Phenotype; Rats; Rats, Inbred Lew; Specific Pathogen-Free Organisms; Terpenes | 2002 |
No causal association between inflammation and Chlamydia pneumoniae in patients with chronic ischemic arterial disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Bacterial; C-Reactive Protein; Child; Child, Preschool; Chlamydophila Infections; Chlamydophila pneumoniae; Chronic Disease; Coronary Artery Disease; Female; Fibrinogen; Heart Valve Prosthesis; Humans; Infant; Inflammation; Ischemia; Male; Middle Aged; Statistics, Nonparametric | 2002 |
Coagulation indicators in chronic stable effort angina and unstable angina: relationship with acute phase reactants and clinical outcome.
Topics: Acute-Phase Proteins; Aged; Angina Pectoris; Angina, Unstable; Biomarkers; Blood Proteins; C-Reactive Protein; Chronic Disease; Death, Sudden, Cardiac; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Neoplasm Proteins; Peptide Fragments; Peroxidases; Peroxiredoxin III; Peroxiredoxins; Physical Exertion; Prognosis; Protein Isoforms; Prothrombin; Risk Factors; Treatment Outcome; Troponin I | 2002 |
Diabetic retinopathy and the fibrinolytic system.
Topics: Age Factors; Aged; Alpha-Globulins; Blood Vessels; Chronic Disease; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Retinopathy; Enzyme Activation; Female; Fibrinogen; Fibrinolysis; Humans; Macroglobulins; Male; Obesity; Plasminogen; Time Factors | 1975 |
Role of local hyperfibrinolysis in the etiology of chronic subdural hematoma.
Topics: Cerebral Hemorrhage; Chronic Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Hematoma, Subdural; Humans; Plasminogen | 1976 |
[In vitro studies to elucidate the fibrinolytic activity in cerebrospinal fluid altered by inflammation and hemorrhage and having pathologic protein values].
Topics: Central Nervous System Diseases; Cerebrospinal Fluid Proteins; Chronic Disease; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Hemorrhage; Humans; Inflammation; Plasminogen | 1977 |
Abnormal fibrin polymerization in liver disease.
Topics: Batroxobin; Blood Coagulation Tests; Carcinoma, Hepatocellular; Cholestasis; Chronic Disease; Fibrin; Fibrinogen; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Polymers; Thrombin; Time Factors | 1976 |
Coagulation abnormalities in liver disease.
Topics: Acute Disease; Antithrombins; Blood Coagulation Disorders; Blood Coagulation Tests; Carcinoma, Hepatocellular; Chronic Disease; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XIII; Fibrinogen; Hepatitis; Humans; Jaundice, Chronic Idiopathic; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Liver Neoplasms; Neoplasm Metastasis; Prothrombin; Vitamin K | 1977 |
Localized chronic pemphigoid. Report of a case, review of the literature and discussion of the relationship with cicatricial pemphigoid.
Topics: Albumins; Chronic Disease; Complement System Proteins; Female; Fibrinogen; Fluorescent Antibody Technique; Humans; Immune Sera; Immunoglobulins; Middle Aged; Skin Diseases, Vesiculobullous; Skin Tests | 1978 |
Fibrinogen and FDP-E antigen deposits in nephritic kidneys.
Topics: Acute Disease; Adolescent; Adult; Aged; Antigen-Antibody Reactions; Antigens; Chronic Disease; Diabetic Nephropathies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fluorescent Antibody Technique; Glomerulonephritis; Humans; Kidney Diseases; Kidney Glomerulus; Lupus Erythematosus, Systemic; Male; Middle Aged; Nephritis; Nephrosis, Lipoid | 1978 |
Induction of extraglomerular renal damage in experimental chronic serum sickness. I. Histologic and immunofluorescence findings.
Topics: Animals; Antigen-Antibody Complex; Chronic Disease; Complement C3; Fibrinogen; Fluorescent Antibody Technique; Immunoglobulin G; Kidney; Kidney Glomerulus; Kidney Tubules; Rabbits; Serum Albumin; Serum Sickness; Time Factors | 1979 |
Immunohistologic findings in the glomerular crescents in various renal diseases.
Topics: Acute Disease; Adult; Chronic Disease; Female; Fibrinogen; Fluorescent Antibody Technique; Glomerulonephritis; Humans; Immunoglobulins; Kidney Glomerulus; Male | 1979 |
Immunofluorescence study of renal biopsies in chronic rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Chronic Disease; Complement C3; Female; Fibrinogen; Fluorescent Antibody Technique; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Kidney; Male; Middle Aged | 1979 |
[Blood sterol-fibrinogen complexes in chronic ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Chronic Disease; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Protein Binding; Sterols | 1979 |
Problem of abnormal hemostasis in liver disease.
Topics: Acute Disease; Blood Coagulation Factors; Chronic Disease; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Hemostasis; Hepatic Encephalopathy; Hepatitis, Alcoholic; Humans; Thrombocytopenia; Thrombosis | 1979 |
[Blood fibrinogen-bound sterols in ischemic heart disease].
Topics: Adult; Cholesterol; Chronic Disease; Coronary Disease; Female; Fibrinogen; Free Radicals; Humans; Lipids; Male; Middle Aged; Protein Binding; Sterols | 1979 |
Association of abnormal fibrin polymerisation with severe liver disease.
Topics: Aspartate Aminotransferases; Bilirubin; Blood Coagulation Disorders; Chronic Disease; Factor VII; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Liver Diseases; Prothrombin Time; Serum Albumin; Serum Globulins | 1977 |
Induced chronic intravascular coagulation in dogs.
Topics: Animals; Chronic Disease; Disseminated Intravascular Coagulation; Dogs; Factor VIII; Fibrinogen; Heparin; Platelet Factor 4; Prothrombin; Thromboplastin | 1977 |
[Changes in systemic blood viscosity in subjects with regional chronic vasculopathies during spontaneous and induced ischemia].
Topics: Adult; Angina Pectoris; Arterial Occlusive Diseases; Blood Viscosity; Chronic Disease; Coronary Disease; Diabetic Angiopathies; Diabetic Retinopathy; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Osmotic Fragility | 1977 |
[S-adenosylmethionine as a regulator of protein synthesis. Influence on plasmatic fibrinogen].
Topics: Adult; Aged; Blood Sedimentation; Blood Viscosity; Chronic Disease; Female; Fibrinogen; Humans; Liver Diseases; Male; Middle Aged; S-Adenosylmethionine; Thrombelastography | 1977 |
[Clinico-biochemical evaluation of the activity of chronic pneumonia].
Topics: Adolescent; Adult; Blood Proteins; Chronic Disease; Female; Fibrinogen; Haptoglobins; Humans; Male; Middle Aged; Pneumonia; Sialic Acids | 1977 |
Acquired dysfibrinogenaemia in acute and chronic liver disease.
Topics: Acute Disease; Ancrod; Batroxobin; Blood Coagulation Disorders; Blood Coagulation Tests; Chronic Disease; Fibrin; Fibrinogen; Humans; Liver Diseases; Thrombin | 1977 |
Coagulation and fibrinolytic properties of peripheral venous blood in chronic ectopic pregnancy.
Topics: Adult; Blood Coagulation; Chronic Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Pregnancy; Pregnancy, Ectopic; Serum Globulins; Veins | 1976 |
Chronic ulcerative colitis, skin necrosis, and cryofibrinogenemia.
Topics: Blood Protein Disorders; Chronic Disease; Cold Temperature; Colitis, Ulcerative; Fibrinogen; Humans; Male; Middle Aged; Necrosis; Skin Diseases; Warfarin | 1976 |
Venous disease and its complications.
Topics: Aged; Anticoagulants; Chronic Disease; Drug Administration Schedule; Femoral Vein; Fibrinogen; Heparin; Humans; Iliac Vein; Infusions, Parenteral; Injections, Intravenous; Injections, Subcutaneous; Middle Aged; Pneumonia; Pulmonary Embolism; Thrombophlebitis; Varicose Veins; Vascular Diseases | 1976 |
[Fibrinogen concentration and its ratio to other protein fractions in chronic alcoholism].
Topics: Adolescent; Adult; Aged; Chronic Disease; Fibrinogen; Humans; Liver Diseases; Middle Aged; Serum Albumin; Serum Globulins | 1976 |
Analysis of the disappearance curve of labelled fibrinogen at the time of hyperfibrinogenemia in rabbits with acute or chronic intravascular coagulation.
Topics: Acute Disease; Animals; Chronic Disease; Disseminated Intravascular Coagulation; Fibrinogen; Half-Life; Iodine Radioisotopes; Rabbits | 1976 |
Hypofibrinogenaemia as a cause of bleeding in chronic myeloid leukaemia.
Topics: Afibrinogenemia; Aged; Blood Cell Count; Bone Marrow Cells; Busulfan; Chronic Disease; Disseminated Intravascular Coagulation; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Hypoprothrombinemias; Immunoelectrophoresis; Leukemia, Myeloid; Thrombin | 1975 |
Polycythemia following renal transplantation.
Topics: Adult; Azathioprine; Chronic Disease; Creatinine; Female; Fibrinogen; Humans; Kidney Transplantation; Male; Middle Aged; Polycythemia; Postoperative Complications; Prednisone; Transplantation, Homologous | 1975 |
[Kininogen level and kininase activity in the blood plasma in chronic stage I and II pneumonia in adults].
Topics: Adolescent; Adult; Alkaline Phosphatase; Asthma; Chronic Disease; Endopeptidases; Female; Fibrinogen; Humans; Kininogens; Leukocytes; Male; Pneumonia | 1975 |
[Therapy of chronic peripheral arterial occlusive diseases with snake venom enzyme Arwin].
Topics: Arterial Occlusive Diseases; Blood Viscosity; Chronic Disease; Enzymes; Erythrocyte Aggregation; Fibrinogen; Hematocrit; Hemodynamics; Humans; Regional Blood Flow; Rheology; Snake Venoms | 1975 |
[Changes of blood-flow properties in patients with chronic liver disease (author's transl)].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Viscosity; Chronic Disease; Cortisone; Esophageal and Gastric Varices; Fibrinogen; Hepatitis; Humans; Hypertension, Portal; Immunoglobulin G; Immunosuppression Therapy; Liver Cirrhosis; Liver Diseases; Middle Aged | 1975 |
[Plasma fibrinogen level in peptic ulcer and gastric cancer].
Topics: Chronic Disease; Fibrinogen; Humans; Peptic Ulcer; Stomach Neoplasms | 1975 |
Cardiovascular lesions in pancreatitis.
Topics: Acute Disease; Adult; Amylases; Blood Coagulation; Blood Coagulation Tests; Capillary Permeability; Chronic Disease; Coronary Disease; Electrocardiography; Female; Fibrinogen; Fibrinolysis; Glucuronidase; Hemorrhage; Humans; Middle Aged; Pancreatic Elastase; Pancreatitis; Thrombelastography; Trypsin; Trypsin Inhibitors | 1975 |
Fibrinogen metabolism in acute hepatitis and active chronic hepatitis.
Topics: Acute Disease; Blood Coagulation Tests; Chronic Disease; Fibrinogen; Hepatitis; Hepatitis A; Humans | 1975 |
Immunofluorescent identification of fibronectin and fibrinogen/fibrin in experimental myocardial infarction.
Topics: Animals; Antibodies; Antibodies, Monoclonal; Arteries; Chronic Disease; Coronary Aneurysm; Coronary Vessels; Epitopes; Fibrin; Fibrinogen; Fibronectins; Fluorescent Antibody Technique; Granulation Tissue; Ligation; Male; Myocardial Infarction; Myocardium; Rats; Rats, Inbred Strains | 1990 |
[Chronic intermittent urokinase therapy in therapy-refractory angina pectoris].
Topics: Aged; Angina Pectoris; Blood Viscosity; Chronic Disease; Coronary Disease; Drug Evaluation; Exercise Test; Fibrinogen; Heart; Humans; Injections, Intravenous; Male; Middle Aged; Radionuclide Imaging; Thallium Radioisotopes; Time Factors; Urokinase-Type Plasminogen Activator | 1992 |
Hemorrheological changes in chronic hepatitis and liver cirrhosis and their relations to the syndromes differentiated by traditional Chinese medicine.
Topics: Adult; Blood Viscosity; Chronic Disease; Female; Fibrinogen; Hepatitis, Viral, Human; Humans; Liver Cirrhosis; Male; Medicine, Chinese Traditional; Middle Aged; Regional Blood Flow; Tongue | 1990 |
Coagulation-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism.
Topics: Acute Disease; Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; Blood Coagulation; Cerebrovascular Disorders; Chronic Disease; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemostasis; Humans; Intracranial Embolism and Thrombosis; Male; Tomography, X-Ray Computed | 1990 |
[The role of immunologic factors in the pathogenesis of urolithiasis].
Topics: Adult; Chronic Disease; Crystallization; Fibrinogen; Humans; Immune Adherence Reaction; Immunoglobulins; Middle Aged; Opsonin Proteins; Thrombin; Urinary Calculi | 1990 |
Chronic osteomyelitis treated by cancellous homografts and fibrin adhesion.
Topics: Adolescent; Adult; Aged; Aprotinin; Bone Cements; Bone Transplantation; Child; Chronic Disease; Drug Combinations; Factor XIII; Female; Fibrin Tissue Adhesive; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Osteomyelitis; Thrombin | 1987 |
[Surgery of the thoracic aorta. Value of tissucol].
Topics: Aorta, Thoracic; Aortic Aneurysm; Aortic Dissection; Aprotinin; Chronic Disease; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Hemostatic Techniques; Humans; Thrombin; Tissue Adhesives | 1988 |
[Occlusion therapy in chronic recurrent parotitis? A report of clinical experiences with the use of a fibrin glue-gentamycin mixture].
Topics: Aprotinin; Chronic Disease; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Follow-Up Studies; Gentamicins; Humans; Injections; Methylmethacrylates; Parotid Gland; Parotitis; Recurrence; Thrombin | 1988 |
Indices of growth and death of liver cells in human chronic liver disease.
Topics: alpha-Fetoproteins; Aspartate Aminotransferases; Chronic Disease; Fibrinogen; gamma-Glutamyltransferase; Humans; Liver; Liver Diseases; Liver Regeneration; Ornithine Carbamoyltransferase; Thrombin Time | 1987 |
Fibrin glue achieves hemostasis in patients with coagulation disorders.
Topics: Adult; Aged; Aprotinin; Blood Coagulation Disorders; Chronic Disease; Disseminated Intravascular Coagulation; Drug Combinations; Factor XIII; Female; Fibrin; Fibrin Tissue Adhesive; Fibrinogen; Hemostasis, Surgical; Humans; Liver; Male; Spleen; Thrombin; Tissue Adhesives; Transfusion Reaction | 1989 |
[Coagulation and fibrinolysis in chronic subdural hematoma. Measurement of fibrinopeptides].
Topics: Adult; Aged; Blood Coagulation; Chronic Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinopeptide A; Fibrinopeptide B; Hematoma, Subdural; Humans; Middle Aged; Peptide Fragments | 1989 |
Enhanced erythrocyte aggregability in occlusive cerebrovascular disease.
Topics: Acute Disease; Adult; Aged; Alpha-Globulins; Cerebrovascular Disorders; Chronic Disease; Erythrocyte Aggregation; Female; Fibrinogen; Globulins; Humans; Leukocyte Count; Male; Middle Aged; Serum Albumin | 1989 |
[Anti-fibrinogen antibodies in chronic diseases of the liver].
Topics: Adult; Autoantibodies; Chronic Disease; Fatty Liver; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hepatitis; Humans; Liver Cirrhosis; Male; Middle Aged | 1989 |
[Hemorheological alterations in patients with chronic cerebral ischemia].
Topics: Aged; Blood Volume; Brain Ischemia; Chronic Disease; Erythrocyte Deformability; Female; Fibrinogen; Humans; Male; Middle Aged | 1989 |
[Effects of buflomedil hydrochloride on the rheological properties of the blood in chronic cerebrovascular diseases].
Topics: Aged; Blood Viscosity; Cerebrovascular Disorders; Chronic Disease; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Humans; Leukocyte Count; Male; Pyrrolidines; Vasodilator Agents | 1989 |
Lipomembranous changes in chronic panniculitis.
Topics: Adipose Tissue; Adult; Aged; Chronic Disease; Female; Fibrinogen; Fibrosis; Fluorescent Antibody Technique; Humans; Lipodystrophy; Male; Membranes; Middle Aged; Panniculitis, Nodular Nonsuppurative; Skin | 1988 |
Clinical significance of cross-linked fibrin degradation products in essential mixed cryoglobulinemia.
Topics: Adult; Aged; Chronic Disease; Cryoglobulinemia; Disseminated Intravascular Coagulation; Enzyme-Linked Immunosorbent Assay; Female; Fibrin; Fibrinogen; Humans; Male; Middle Aged | 1988 |
Haematology of clinically normal and abnormal captive llamas and guanacoes.
Topics: Acute Disease; Animals; Animals, Zoo; Artiodactyla; Camelids, New World; Chronic Disease; Diarrhea; Eosinophils; Erythrocyte Count; Erythrocytes; Fibrinogen; Hematocrit; Hemoglobins; Inflammation; Intestinal Diseases, Parasitic; Leukocyte Count; Lymphocytes; Parasitic Diseases; Parasitic Diseases, Animal; Platelet Count; Reference Values | 1988 |
[Possibilities of bronchoscopy in evaluating the activity of the inflammatory process in chronic bronchitis patients].
Topics: Adolescent; Adult; Blood Proteins; Bronchi; Bronchitis; Bronchoscopy; Chronic Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Proteins; Sialic Acids; Sputum | 1987 |
Levels of fibrinopeptide A (FPA) and fibrinopeptide B beta 15-42 (FPB beta) in urine and plasma after urokinase administration in patients with chronic glomerulonephritis.
Topics: Adult; Chronic Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Glomerulonephritis; Glomerulonephritis, IGA; Humans; Peptide Fragments; Urokinase-Type Plasminogen Activator | 1986 |
Fibrinolytic behavior in long-standing branch retinal vein occlusion.
Topics: Aged; Chronic Disease; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Partial Thromboplastin Time; Retinal Vein Occlusion; Serum Globulins; Time Factors | 1987 |
[Detection of fibrinolysis in chronic subdural hematoma].
Topics: Adult; Aged; Blood Protein Electrophoresis; Chronic Disease; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hematoma, Subdural; Humans; Middle Aged; Molecular Weight | 1986 |
Chronic liver disease animal model for evaluation of artificial liver support systems.
Topics: Animals; Body Weight; Chronic Disease; Disease Models, Animal; Dogs; Fibrinogen; Galactosamine; Hepatitis, Chronic; Liver Diseases; Male; Necrosis; Partial Thromboplastin Time; Prothrombin Time | 1985 |
[Experience with fibrin glue in type-III tympanoplasty with stapes elevation].
Topics: Audiometry; Chronic Disease; Drug Combinations; Drug Evaluation; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Humans; Otitis Media; Postoperative Complications; Recurrence; Retrospective Studies; Stapes Mobilization; Thrombin; Time Factors; Tissue Adhesives; Tympanoplasty | 1985 |
[Hemorheologic and blood coagulation studies in 94 patients with chronic obstructive peripheral arterial disease].
Topics: Aged; alpha-2-Antiplasmin; Antithrombin III; Arterial Occlusive Diseases; Blood Coagulation; Blood Viscosity; Chronic Disease; Erythrocyte Deformability; Factor VIII; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time | 1985 |
Effect of venous hypertension on canine hind limb lymph.
Topics: Acute Disease; Animals; Chronic Disease; Disease Models, Animal; Dogs; Fibrinogen; Hindlimb; Hypertension; Lymph; Male; Venous Pressure | 1985 |
[Blood viscosity indicators in patients with gastric and duodenal diseases].
Topics: Adolescent; Adult; Blood Viscosity; Chronic Disease; Cimetidine; Cyproheptadine; Duodenal Ulcer; Female; Fibrinogen; Gastritis; Hematocrit; Humans; Male; Middle Aged; Stomach Ulcer | 1985 |
[The levels of fibrinopeptide A and fibrinopeptide B beta in the urine from patients with chronic glomerulonephritis during urokinase therapy].
Topics: Adult; Aged; Chronic Disease; Drug Evaluation; Female; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Glomerulonephritis; Humans; Male; Middle Aged; Urokinase-Type Plasminogen Activator | 1985 |
Thrombophlebitis and chronic venous insufficiency.
Topics: Aged; Blood Coagulation Disorders; Chronic Disease; Contraceptives, Oral; Endothelium; Female; Fibrinogen; Gangrene; Humans; Iodine Isotopes; Male; Palpation; Phlebography; Pulmonary Embolism; Reflex Sympathetic Dystrophy; Thrombophlebitis; Venous Insufficiency; Wounds and Injuries | 1973 |
The fibrinolytic enzyme system in acute and chronic liver injury.
Topics: Acute Disease; Adult; Aged; Alcoholism; alpha 1-Antitrypsin; Alpha-Globulins; Chronic Disease; Fatty Liver; Female; Fibrin; Fibrinogen; Fibrinolysis; Hepatitis; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Macroglobulins; Male; Middle Aged; Plasminogen | 1974 |
Chronic intravascular coagulation syndrome.
Topics: Beta-Globulins; Blood Cell Count; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Chronic Disease; Cryoglobulins; Dipyridamole; Female; Fibrinogen; Heparin; Humans; Immunodiffusion; Immunoelectrophoresis; Middle Aged; Ovarian Neoplasms; Ultracentrifugation; Warfarin | 1968 |
[Hepatic involvement during acute respiratory decompensation of chronic broncho-pneumopathies].
Topics: Acidosis, Respiratory; Acute Disease; Alanine Transaminase; Alkaline Phosphatase; Ammonia; Aspartate Aminotransferases; Bilirubin; Bronchitis; Cholesterol; Chronic Disease; Female; Fibrinogen; gamma-Globulins; Humans; Hypercapnia; Hypoxia; L-Lactate Dehydrogenase; Liver; Male; Metabolic Clearance Rate; Prothrombin Time; Respiratory Insufficiency; Serum Albumin; Sulfobromophthalein | 1969 |
[Fibrinolytic activity in cantharide blisters of urticaria patients].
Topics: Blister; Cantharidin; Chronic Disease; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Male; Prothrombin; Thrombin; Urticaria | 1968 |
Fibrinolytic activity in renal disease.
Topics: Cholesterol; Chronic Disease; Creatinine; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Glomerulonephritis; Humans; Hypertension, Malignant; Kidney Diseases; Kidney Function Tests; Male; Nephrosclerosis; Plasminogen; Pyelonephritis; Sodium; Streptokinase; Thiosulfates | 1972 |
[Studies of 131 I fibrinogen storage by the Yoshida sarcoma of rats].
Topics: Acute Disease; Animals; Blood Coagulation; Blood Platelets; Cattle; Chronic Disease; Female; Fibrinogen; Inflammation; Iodine Isotopes; Radionuclide Imaging; Rats; Sarcoma, Yoshida; Time Factors | 1973 |
[Paracoagulation test in renal diseases].
Topics: Blood Coagulation; Blood Coagulation Tests; Chronic Disease; Fibrinogen; Glomerulonephritis; Humans; Kidney Diseases | 1974 |
[State of the blood coagulation process in pulmonary hemorrhage and hemoptysis in patients with pulmonary tuberculosis].
Topics: Adult; Blood Coagulation; Chronic Disease; Factor XIII; Female; Fibrinogen; Fibrinolysis; Hemoptysis; Humans; Male; Middle Aged; Plasminogen; Thromboplastin; Tuberculosis, Pulmonary | 1974 |
[The phenomenon of oblique frequency distribution as exemplified by blood clotting factors. A neglected problem].
Topics: Acute Disease; Blood Coagulation Factors; Chronic Disease; Fibrinogen; Humans; Kidney Diseases; Myocardial Infarction; Probability; Prothrombin; Pulmonary Embolism; Thrombin | 1974 |
[Disseminated intravascular coagulation and lethal macrothrombosis in a patient with carcinoma of the biliary tract (author's transl)].
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Blood Coagulation; Chronic Disease; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Male; Prothrombin; Thrombelastography; Thrombophlebitis; Thromboplastin | 1974 |
Coagulation factors as indicators of protein synthesis in chronic liver disease.
Topics: Blood Cell Count; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Chronic Disease; Female; Fibrinogen; Hepatitis; Humans; Indicators and Reagents; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Methods; Serum Albumin | 1973 |
The diagnostic value of coagulation studies in chronic liver disease.
Topics: Blood Coagulation Tests; Chronic Disease; Factor V; Fibrinogen; Hepatitis; Humans; Indicators and Reagents; Liver Cirrhosis; Liver Diseases; Methods; Prothrombin Time | 1973 |
The relevance of blood clotting tests in chronic aggressive hepatitis.
Topics: Analysis of Variance; Antithrombins; Biopsy; Blood Coagulation Tests; Blood Protein Electrophoresis; Chronic Disease; Cyclohexanecarboxylic Acids; Disseminated Intravascular Coagulation; Factor V; Factor X; Fibrinogen; Heparin; Hepatitis; Humans; Immunoelectrophoresis; Indicators and Reagents; Liver Function Tests; Macroglobulins; Methods; Prothrombin Time; Serum Albumin | 1973 |
[Improvement of flow properties of blood: a new principle for drug therapy of chronic peripheral arterial vascular disorders].
Topics: Animals; Antifibrinolytic Agents; Arterial Occlusive Diseases; Blood Viscosity; Chronic Disease; Erythrocytes; Extremities; Fibrinogen; Humans; Peptide Hydrolases; Snakes; Streptokinase; Venoms | 1973 |
[Kidney and hemostasis. I. Significance of the fibrinogen-similar material in immunologic renal diseases and in crisis of transplanted kidney rejection].
Topics: Acute Disease; Antigen-Antibody Complex; Chronic Disease; Fibrinogen; Glomerulonephritis; Graft Rejection; Hemostasis; Histocompatibility Antigens; Humans; Kidney Transplantation; Proteinuria; Transplantation, Homologous | 1972 |
Splenomegaly associated with chronic consumption coagulopathy.
Topics: Adult; Aged; Chronic Disease; Disseminated Intravascular Coagulation; Factor V; Factor VII; Female; Fibrin; Fibrinogen; Gaucher Disease; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Organ Size; Plasminogen; Polycythemia Vera; Prothrombin Time; Spleen; Splenectomy; Splenomegaly | 1974 |
Failure to demonstrate immunoglobulin E in glomeruli of patients with various nephropathies.
Topics: Amyloidosis; Animals; Biopsy; Chromatography, Gel; Chronic Disease; Complement System Proteins; Fibrinogen; Fluorescent Antibody Technique; Glomerulonephritis; Hematuria; Humans; Immunoglobulin E; Kidney Diseases; Kidney Glomerulus; Kidney Transplantation; Microscopy, Fluorescence; Nephritis; Nephritis, Interstitial; Nephrosis; Rabbits; Transplantation, Homologous | 1974 |
[Autoimmune nature of the nephropathy in suppurative diseases of the lungs and pleura].
Topics: Adult; Aged; Autoimmune Diseases; Biopsy, Needle; Bronchiectasis; Chronic Disease; Empyema; Female; Fibrin; Fibrinogen; Fluorescent Antibody Technique; Humans; Kidney; Kidney Diseases; Lung; Lung Diseases; Male; Microscopy, Electron; Middle Aged; Phagocytosis; Pleural Diseases; Pneumonia | 1974 |
[Non-enzymatic fibrinolytic activity of the plasma of animals under chronic stress].
Topics: Acute Disease; Animals; Arteriosclerosis; Chronic Disease; Fibrinogen; Fibrinolysis; Heparin; Male; Rats; Stress, Physiological | 1972 |
[Fibrinogen-fibrin degradation products (FDP) in patients with various diseases].
Topics: Adolescent; Adult; Angina Pectoris; Chronic Disease; Diabetes Mellitus; Female; Fibrin; Fibrinogen; Hematologic Diseases; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Myocardial Infarction; Neoplasms | 1972 |
Disseminated intravascular coagulation.
Topics: Blood Cell Count; Blood Platelets; Chronic Disease; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Fibrinolysis; Heparin; Humans; Liver Cirrhosis; Pregnancy; Pregnancy Complications, Hematologic; Prothrombin Time; Thrombin; Thromboplastin | 1973 |
Chronic intravascular coagulation syndrome associated with atherosclerotic aortic aneurysm.
Topics: Aged; Aortic Aneurysm; Arteriosclerosis; Aspirin; Blood Cell Count; Blood Platelets; Chronic Disease; Coronary Disease; Dipyridamole; Disseminated Intravascular Coagulation; Female; Fibrinogen; Heparin; Humans; Time Factors | 1973 |
[Plasmatic haptoglobin in chronic coronary disease and in myocardial infarct. Physiopathological significance. Diagnostic importance].
Topics: Arteriosclerosis; Chronic Disease; Coronary Disease; Fibrinogen; Haptoglobins; Humans; Myocardial Infarction | 1973 |
[Sputum findings in chronic bronchitis].
Topics: Bronchitis; Chronic Disease; Cytodiagnosis; DNA; Fibrinogen; Humans; L-Lactate Dehydrogenase; Leukocyte Count; Methods; Sputum; Time Factors | 1973 |
[Fibrinogen level and its relation to other biochemical parameters in nephrotic syndrome].
Topics: Adolescent; Adult; Aged; Amyloidosis; Chronic Disease; Female; Fibrinogen; Glomerulonephritis; Humans; Lipids; Male; Middle Aged; Nephrotic Syndrome; Proteinuria | 1973 |
A study of intravascular coagulation in immune complex glomerulonephritis by use of 131-I-labelled fibrinogen and 125I-labelled antigen.
Topics: Acute Disease; Anaphylaxis; Animals; Antibodies; Antigen-Antibody Complex; Antigens; Blood Coagulation; Blood Coagulation Tests; Cattle; Chronic Disease; Fibrinogen; Glomerulonephritis; Horses; Immunization Schedule; Iodine Isotopes; Precipitins; Proteinuria; Rabbits; Serum Albumin, Bovine; Serum Sickness | 1973 |
[Blood coagulation disorders in a chronic eosinophilic leukemia].
Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Chronic Disease; Eosinophils; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Leukemia; Male; Thrombocytopenia | 1973 |
Therapeutic problems of disseminated intravascular coagulation.
Topics: Acute Disease; Aged; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Disorders; Blood Coagulation Tests; Chronic Disease; Diagnosis, Differential; Disseminated Intravascular Coagulation; Fibrinogen; Fibrinolysis; Heparin; Humans; Male; Prothrombin Time | 1973 |
[Research on thrombogenesis in chronic obliterating arteriopathies of the extremities].
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis Obliterans; Blood Coagulation Disorders; Chronic Disease; Coronary Disease; Extremities; Female; Fibrinogen; Humans; Lipids; Lipoproteins; Male; Middle Aged; Platelet Adhesiveness; Smoking; Thromboangiitis Obliterans; Thrombosis | 1973 |
Laboratory control of SK therapy.
Topics: Acute Disease; Arterial Occlusive Diseases; Blood Coagulation; Blood Coagulation Tests; Chronic Disease; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Peptide Hydrolases; Plasminogen; Recurrence; Serum Globulins; Snake Venoms; Solubility; Streptokinase; Thrombelastography; Thrombin; Time Factors | 1973 |
Chronic intravascular coagulation: localized or generalized? With evidence for thrombus turnover.
Topics: Adult; Aged; Aneurysm; Aortic Aneurysm; Arteriosclerosis; Blood Cell Count; Blood Coagulation; Blood Platelets; Buttocks; Cell Survival; Chromium Radioisotopes; Chronic Disease; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Hemangioma; Humans; Iodine Radioisotopes; Middle Aged; Purpura, Thrombocytopenic; Skin Neoplasms; Syndrome; Thrombosis | 1973 |
Newer techniques to detect venous thrombosis with special reference to electrical impedance plethysmography.
Topics: Acute Disease; Blood Circulation; Blood Pressure; Chronic Disease; Collateral Circulation; False Positive Reactions; Femoral Vein; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Methods; Phlebography; Plethysmography, Impedance; Preoperative Care; Respiration; Thrombophlebitis; Tourniquets; Valsalva Maneuver | 1974 |
[State of hemocoagulation in patients with chronic nonspecific pneumonia according to data of biochemical and thromboelastographic studies].
Topics: Adult; Aged; Blood Coagulation; Chronic Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Pneumonia; Thrombelastography; Thromboplastin | 1974 |
[Chronic fibrinolysis in alcoholic cirrhosis].
Topics: Alcoholism; Blood Cell Count; Blood Platelets; Chronic Disease; Fibrinogen; Fibrinolysis; Heparin; Humans; Liver Cirrhosis; Male | 1974 |
The role of immunoglobulin A in endogenous bronchial defense mechanisms in chronic bronchitis.
Topics: Bronchi; Bronchitis; Chronic Disease; DNA; Epithelium; Fibrinogen; Humans; Immunodiffusion; Immunoglobulin A; Immunoglobulin G; Inflammation; L-Lactate Dehydrogenase; Mucous Membrane; Sputum | 1971 |
Local 'Schwartzman equivalent' reaction in active chronic hepatitis.
Topics: Adult; Arm; Blood Cell Count; Blood Coagulation Disorders; Blood Platelets; Buttocks; Chronic Disease; Disseminated Intravascular Coagulation; Factor V; Factor VIII; Female; Fibrinogen; Fibrinolysis; Heparin; Hepatitis; Humans; Leg; Prothrombin Time; Purpura; Shwartzman Phenomenon | 1972 |
[A special form of chronic glomerulonephritis: IgA-IgG nephropathy].
Topics: Adult; Antigen-Antibody Complex; Biopsy; Chronic Disease; Diagnosis, Differential; Female; Fibrinogen; Glomerulonephritis; Hematuria; Histocytochemistry; Humans; Immunoassay; Immunoglobulin A; Immunoglobulin E; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Male; Proteinuria | 1972 |
Elevated heparin-precipitable fraction (HPF) in patients with uveitis.
Topics: Blood Coagulation; Blood Sedimentation; Chemical Precipitation; Chronic Disease; Cold Temperature; Fibrinogen; Glucocorticoids; Heparin; Humans; Inflammation; Uveitis | 1971 |
Fibrinolytic activity in hemiplegic patients.
Topics: Adult; Arm; Chronic Disease; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemiplegia; Humans; Immobilization; Leg; Macroglobulins; Male; Middle Aged; Plasminogen; Posture; Pre-Eclampsia; Pregnancy; Thrombophlebitis | 1971 |
[Functional state of the blood coagulation and anti-coagulation system in the chronic form of viral hepatitis (Botkin's disease)].
Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Factors; Chronic Disease; Female; Fibrinogen; Globulins; Hepatitis A; Humans; Liver; Liver Function Tests; Male; Middle Aged; Prothrombin Time; Thrombin | 1971 |
[Therapy of blood coagulation disorders in chronic asphyxia neonatorum].
Topics: Asphyxia Neonatorum; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Transfusion; Chronic Disease; Fibrinogen; Heparin; Humans; Infant, Newborn; Plasma Substitutes | 1971 |
[Various aspects of the pathogenesis of thrombophlebitis].
Topics: Acute Disease; Adult; Aged; Blood Coagulation Disorders; Chronic Disease; Factor V; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Thrombelastography; Thrombin; Thrombophlebitis | 1971 |
[Changes in the fibrinogen content and fibrinolytic activity of the blood of children with chronic tonsillitis in connection with tonsillectomy].
Topics: Adolescent; Child; Child, Preschool; Chronic Disease; Fibrinogen; Fibrinolysis; Humans; Tonsillectomy; Tonsillitis | 1971 |
[Biochemical criteria of the activity of chronic pneumonia].
Topics: Blood Proteins; Ceruloplasmin; Chronic Disease; Fibrinogen; Humans; Pneumonia; Trace Elements; Transaminases; Transferrin | 1971 |
Chronic intravascular coagulation. Clinical spectrum and diagnostic criteria, with special emphasis on metabolism, distribution and localization of I 131 -fibrinogen.
Topics: Adolescent; Adult; Aged; Anticoagulants; Antifibrinolytic Agents; Blood Cell Count; Blood Coagulation Factors; Chronic Disease; Disseminated Intravascular Coagulation; Factor V; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Immunoelectrophoresis; Iodine Radioisotopes; Male; Middle Aged; Plasma Volume; Plasminogen; Secretory Rate; Serum Globulins; Thrombelastography; Urine | 1971 |
[Indices of the coagulation and anticoagulation system of the blood under the influence of proteolytic enzyme treatment of patients with chronic nonspecific processes in the lung].
Topics: Adolescent; Adult; Aged; Blood Coagulation; Chronic Disease; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Lung Diseases; Male; Middle Aged; Peptide Hydrolases | 1969 |
Chronic intravascular coagulation (IFC) syndrome.
Topics: Blood Coagulation Disorders; Chromium Isotopes; Chronic Disease; Fibrinogen; Hemangioma; Hemoglobinuria, Paroxysmal; Humans; Iodine Isotopes; Liver Diseases; Neoplasms; Purpura, Thrombotic Thrombocytopenic; Thrombocytopenia | 1969 |
[Studies on chronic potassium deficiency in man. II. Analysis of kalliopenic proteinuria].
Topics: Adult; Antigens; Chronic Disease; Electrophoresis; Female; Fibrinogen; Humans; Hypokalemia; Immunoelectrophoresis; Kidney Tubules; Macromolecular Substances; Male; Middle Aged; Necrosis; Potassium Deficiency; Proteinuria | 1970 |
Augmentation of albumin but not fibrinogen synthesis by corticosteroids in patients with hepatocellular disease.
Topics: Adult; Albumins; Body Weight; Carbon Isotopes; Chronic Disease; Female; Fibrinogen; Hepatitis; Humans; Liver Cirrhosis; Male; Middle Aged; Plasma Volume; Prednisolone; Serum Albumin | 1970 |
Anticoagulation by ancrod for haemodialysis.
Topics: Adult; Anticoagulants; Cellophane; Chronic Disease; Fibrin; Fibrinogen; Heparin; Humans; Leukocytes; Male; Membranes, Artificial; Middle Aged; Nephritis; Polycystic Kidney Diseases; Renal Dialysis; Urea; Venoms | 1970 |
Indomethacin and urinary excretion of fibrinogen-like material in proliferative glomerulonephritis.
Topics: Agglutination Tests; Blood Platelets; Cell Aggregation; Chronic Disease; Fibrinogen; Glomerulonephritis; Hemagglutination Inhibition Tests; Humans; Indomethacin; Proteinuria; Staphylococcus | 1970 |
[Fibrinogen level in chronic-recurring urticaria].
Topics: Adolescent; Adult; Afibrinogenemia; Child; Chronic Disease; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Recurrence; Urticaria | 1970 |
[State of the blood coagulation and anti-coagulation system in patients with chronic coronary insufficiency in the post-infarct period].
Topics: Blood Coagulation; Chronic Disease; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Male; Myocardial Infarction; Prothrombin; Thrombin; Thrombosis | 1971 |
[Various indices of the blood clotting and anti-clotting systems in chronic alcohlism and theirsynamics during Antbuse therapy].
Topics: Adult; Alcoholism; Blood Coagulation; Calcium; Chronic Disease; Disulfiram; Fibrinogen; Fibrinolysis; Heparin; Humans; Liver; Male; Middle Aged; Prothrombin; Serum Albumin | 1971 |
[Determination of fibrinogen and fibrinolytic activity of the blood in lung cancer, chronic non-specific pneumonia and exudative pleuritis].
Topics: Adult; Chronic Disease; Fibrinogen; Fibrinolysis; Humans; Lung Neoplasms; Pleurisy; Pneumonia | 1967 |
Hypercoagulability associated with chronic ulcerative colitis: changes in blood coagulation factors.
Topics: Adolescent; Adult; Aged; Blood Coagulation Factors; Blood Coagulation Tests; Chronic Disease; Colitis, Ulcerative; Factor IX; Factor VII; Factor VIII; Factor X; Factor XII; Female; Fibrinogen; Humans; Male; Middle Aged; Thromboembolism; Thromboplastin | 1968 |
Investigations on the blood clotting system in the syndrome of chronic cor pulmonale.
Topics: Aged; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Chronic Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Plasma; Prothrombin Time; Pulmonary Heart Disease; Thrombelastography; Thromboembolism | 1968 |
The effect of neuroleptic drug treatment on plasma fibrinogen concentrations in schizophrenic states.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Child; Chronic Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Schizophrenia; Schizophrenia, Childhood; Sex Factors; Statistics as Topic; Tranquilizing Agents | 1968 |
[Changes in the indices of the blood coagulation system in chronic coronary insufficiency in relation to the patient's age, degree and length of illness].
Topics: Adult; Age Factors; Aged; Blood Coagulation; Blood Coagulation Tests; Calcium; Chronic Disease; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Male; Middle Aged; Prothrombin Time; Time Factors | 1968 |
[On the problem of the pathogenetic characteristics of arteriosclerosis during chronic lung diseases].
Topics: Adult; Animals; Arteriosclerosis; Asphyxia; Asthma; Bronchitis; Cholesterol; Chronic Disease; Electrophoresis; Female; Fibrinogen; Fibrinolysis; Humans; Lipid Metabolism; Lipids; Lung Diseases; Male; Methods; Oxygen; Pulmonary Edema; Rats; Respiratory Insufficiency; Suppuration | 1968 |
[The effect of intact erythrocytes on plasma thromboplastin activity].
Topics: Arteriosclerosis; Chronic Disease; Erythrocytes; Fibrinogen; Glomerulonephritis; Humans; Kidney Diseases; Lipid Metabolism; Thromboplastin | 1968 |
[Coagulation factors before and after peritoneal dialysis in chronic uremia].
Topics: Adolescent; Adult; Aged; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Chronic Disease; Creatinine; Factor V; Factor VII; Factor VIII; Factor X; Female; Fibrinogen; Humans; Male; Middle Aged; Nitrogen; Peritoneal Dialysis; Prothrombin; Shwartzman Phenomenon; Thrombelastography; Uremia; Uric Acid | 1969 |
[The level of plasma fibrinogen and C-reactive protein in patients with acute and chronic pneumonia].
Topics: Acute Disease; Adolescent; Adult; Aged; C-Reactive Protein; Chronic Disease; Fibrinogen; Humans; Middle Aged; Pneumonia | 1966 |